Bschleipfer T, Oelke M, Rieken M.
Diagnostik und diagnostische Strategie beim benignen Prostatasyndrom : Ein Überblick [Diagnostic procedures and diagnostic strategy for lower urinary tract symptoms/benign prostatic hyperplasia : An overview].
Urologe A. 2019 Mar;58(3):238-247. German. doi: 10.1007/s00120-019-0870-0. PMID: 30796463.
link
Seit 08/2020 Stellv. Klinikdirektorin an der Universitätsklinik und Poliklinik für Urologie, UMH
Seit 01/2019 Stellv. Leitung und Koordinatorin Uroonkologisches Zentrum am UMH
Seit 2016 Beratungsstelle der Deutschen Kontinenz Gesellschaft
Originalarbeiten als Erstautor
Mühlstädt S., Friedl A., Mohammed N., Schumann A., Weigand K., Kawan F., Göllert C., Kahlert C., Theil G., Fischer K., Fornara P.
(2017) Five-year experience with the adjustable transobturator male system for the treatment of male stress urinary incontinence: A single-center evaluation.
World Journal of Urology 35(1), 145-151.
Mühlstädt S., Mischner S., Kranz J., Anheuser P., Mohammed N., Steffens J., Fornara P.
(2018) Quo Vadis Botulinum Toxin: Normative Constraints and Quality of Life for Patients With Idiopathic OAB?Front Surg. 5, 61.
Anheuser P., Mühlstädt S., Kranz J., Schneidewind L., Steffens J., Fornara P.
(2018) Significance of Hyperbaric Oxygenation in the Treatment of Fournier’s Gangrene: A Comparative
Study. Urologia Internationales 16, 1-5.
Mühlstädt S., Friedl A., Zachoval R., Mohammed N., Schumann A., Theil G., Fornara P.
(2019) An overview of the ATOMS generations: Port types, functionality and risk factors.
World Journal of Urology 37(8), 1679-1686.
Mühlstädt S., Angulo J.C., Mohammed N., Schumann A., Fornara P.
(2019) Complications of the urinary incontinence system ATOMS: Description of risk factors and how to prevent these pitfalls.
World J Urol. doi: 10.1007/s00345-019-02962-w [Epub ahead of print].
Schönburg S., Bauer W., Mohammed N., Brössner C., Fornara P.
(2019) OAB after ATOMS: An underestimated problem or a rare side effect?
Front Surg. 6, 72.
Schönburg S., Bukethal T., Fornara P.
(2020) Does age alone negatively predict the outcome of sacral neuromodulation? A single-centre retrospective observational study.
BMC Urol. 20, 55.
Schönburg S., Anheuser P., Kranz J., Fornara P., Oubaid
(2020) Cognitive training for robotic surgery: A chance to optimize surgical training? A pilot study.
J Robotic Surg, DOI 10.1007/s11701-020-01167-3.
Schönburg S., Murgas S., Fornara P., Michel M.
(2022) Associations between the Patient Perception of Bladder Condition score and overactive bladder syndrome symptoms at baseline and upon treatment.
Neurourol Urodyn. 2022;1–7.
Originalarbeiten als Ko-Autor
Liatsikos E., Mühlstädt S., Kallidonis P., Rabenalt R., Do M., Burchardt M., Herrmann T.R., Stolzenburg J.-U.
(2008) Performance and functional outcome of endoscopic extraperitoneal radical prostatectomy in relation to obesity – An assessment of 500 patients.
British Journal of Urology International 102(6), 718-722.
Friedl A., Mühlstädt S., Rom M., Kivaranovic D., Mohammed N., Fornara P., Brössner C.
(2016) Risk Factors for Treatment Failure With the Adjustable Transobturator Male System Incontinence Device: Who Will Succeed, Who Will Fail? Results of a Multicenter Study.
Urology 90, 189-94.
Kranz J., Schneidewind L., Barski D., Tahbaz R., Huppertz N., Zerrenner C., Grabbert M., Mühlstädt S., Queissert F., Schott S., Grundl S., Boymanns A., Steffens J., Pelzer A.E.
(2016) Urogynäkologische Aus- und Weiterbildungssituation in Deutschland.
Der Urologe 55(8), 1038-1046.
Friedl A., Mühlstädt S., Zachoval R., Giammò A., Kivaranovic D., Rom M., Fornara P., Brössner C.
(2017) Long-term outcome of the adjustable transobturator male system (ATOMS): results of a European multicentre study.
British Journal of Urology International 119(5), 785-792.
Barski D., Gerullis H., Ecke T., Kranz J., Schneidewind L., Leistner N., Queissert F., Mühlstädt S., Grabbert M., Tahbaz R., Pelzer A.E., Joukhadar R., Klinge U., Boros M., Bader W., Naumann G., Puppe F., Otto T.
(2017) Registry of implants for the reconstruction of pelvic floor in males and females: A feasibility case series.
International Journal of Surgery 42, 27-33.
Friedl A., Schneeweiss J., Stangl K., Mühlstädt S., Zachoval R., Hruby S., Gründler T., Kivaranovic D., Fornara P., Lusuardi L., Brössner C.
(2017) The Adjustable Transobturator Male System in Stress Urinary Incontinence After Transurethral Resection of the Prostate.
Urology 109, 184-189.
Kranz J., Schlager D., Anheuser P., Mühlstädt S., Brücher B., Frank T., Barski D., Mayr R., Lunacek A., Macharia-Nimietz E.F., Steffens J.A., Grolle J., Pelzer A., Schneidewind L.
(2018) Desperate need for better management of Fournier’s gangrene.
Cent European J Urol. 71(3), 360-365.
Kranz J., Schlager D., Mühlstädt S., Schneidewind L.
(2019) Barrieren der Leitlinienadhärenz: Identifizierung von Barrieren der Leitlinienadhärenz am Beispiel einer Umfrage zur AWMF S3-Leitlinie Epidemiologie, Diagnostik, Therapie und Management unkomplizierter bakterieller ambulant erworbener Harnwegsinfektionen bei erwachsenen Patienten.
Der Urologe 58(9), 1019-1028.
Anheuser P., Kranz J., Stolle E., Höflmayer D., Büscheck F., Mühlstädt S., Lock G., Dieckmann K.-P.
(2019) Testicular epidermoid cysts: A reevaluation.
BMC Urol. 19(1), 52.
Anheuser P., Mühlstädt S., Fornara P., Steffens J., Dieckmann K.P., Kranz J.
(2019) Kenntnisstand und Früherkennung maligner Keimzelltumoren des Hodens unter Jugendlichen und jungen Erwachsenen.
Der Urologe 58(11), 1331-1337.
Angulo J.C., Schönburg S., Giammò A., Abellán F.J., Arance I., Lora D.
(2019) Systematic review and meta-analysis comparing Adjustable Transobturator Male System (ATOMS) and Adjustable Continence Therapy (ProACT) for male stress incontinence.
PLoS One. 14(12), e0225762.
Angulo J.C., Schönburg S., Giammò A., Queissert F., Gonsior A., González-Enguita C., Martins F.E., Rourke K., Cruz F.
(2021) Artificial urinary sphincter or a second adjustable transobturator male system offer equivalent outcomes in patients whom required revision on the initial ATOMS device: An international multi‐institutional experience.
Neurourol Urodyn., 40(3), 897-909.
Übersichtsarbeiten als Erstautor
Mühlstädt S., Weigand K., Mohammed N., Schumann A., Kawan F., Göllert C., Theil G., Fischer F., Fornara P.
(2016) Living donor nephrectomy: Low surgical risk for high quality grafts.
European Urology Supplements http://dx.doi.org/10.1016/j.eursup.2016.08.003.
Mühlstädt S., Mohammed N., Weigand K., Schumann A., Kawan F., Göllert C., Fornara P.
(2017) Radiation cystitis: Pathophysiology and treatment.
Der Urologe 56(3), 301-305.
Mühlstädt S., Anheuser P., Mohammed N., Bach A.
(2017) Der „buried Penis“ des Erwachsenenalters: Plastisch-chirurgische Rekonstruktion – Pflicht oder Kür?
Der Urologe 56(10), 1266-1273.
Mühlstädt S., Kranz J., Steffens J., Fornara P.
(2017) Therapie der ureteropelvinen Stenose im Erwachsenenalter.
Aktuelle Urol. 48(6), 540-549.
Mühlstädt S.
(2018) Desmopressin zur Therapie der männlichen Nykturie.
Der Urologe 57(4), 458-462.
Mühlstädt S., Heynemann H., Weigand K., Fornara P.
(2018) Tumorscreening bei Transplantationspatienten vor und nach Transplantation.
J. Urol. Urogynäkol. 20, 66–70.
Mühlstädt S., Hüsch T., Bauer R.
(2019) Differenzierte operative Therapie der männlichen Belastungsharninkontinenz – zwischen Wunsch und Wirklichkeit?
Der Urologe 58(6), 640-650.
Mühlstädt S., Oelke M.
(2019) Akuter Harnverhalt bei Männern: Die Wirksamkeit von Alpha-Blockern beim Katheterauslassversuch nach Harnverhalt.
Der Urologe 58(6), 680-685.
Schönburg S., Fornara P.
(2020) Aktuelle politische Aspekte der Transplantationsmedizin in Deutschland: Organspende im Widerspruch?
Der Urologe 59(1), 21-26.
Schönburg S.
(2020) Körperliche Aktivität bei Symptomen der unteren Harnwege infolge einer gutartigen Prostataobstruktion.
Der Urologe 59, 1107-1109.
Schönburg S.
(2021) Prostataobstruktionsassoziierte Symptome der unteren Harnwege – Behandlung mit Anticholinergika in Kombination mit Alpha-Blockern.
Der Urologe 60, 1188-1191.
Übersichtsarbeiten als Ko-Autor
Weigand K., Mühlstädt S., Mohammed N., Schaarschmidt T., Fornara P., Kawan F.
(2015) Lebendnierenspende – ein aktueller Überblick.
Der Urologe 54(10), 1368-1375.
Huppertz N., Kranz J., Mühlstädt S., Schneidewind L., Barski D., Grabbert M., Queissert F., Pelzer A.E.
(2016) GeSRU Academics-Forschungsgruppe „BPS & funktionelle Urologie“.
Der Urologe 55(6), 818-820.
Deininger S., Herrmann T., Schönburg S., Törzsök P., Kunit T., Lusuardi L.
(2020) Die chirurgische Therapie der benignen Prostataobstruktion (BPO) beim antikoagulierten Patienten: Eine Übersichtsarbeit über die Blutungsrisiken etablierter Techniken.
Der Urologe 59, 1187-1194.
Schneidewind L., Anheuser P., Schönburg S., Wagenlehner F., Kranz J.
(2020) Hyperbaric Oxygenation in the Treatment of Fournier’s Gangrene: A Systematic Review.
Urologia Internationalis, doi: 10.1159/000511615, [Online ahead of print].
Kranz J., Schönburg S., Anheuser P., Hüsch T.
(2021) Harnwegsinfektionen bei Frauen – Besonderheiten in der Schwangerschaft, Prä- und Postmenopause.
Nieren- und Hochdruckkrankheiten, Jahrgang 50, 150-155.
2010 Approbation als Arzt
2010-2015 Assistenzarzt in der Urologie des St.Josefs Hospital, Dortmund
2015 Promotion
2015 Facharzt für Urologie
2015 Zusatzbezeichnung Palliativmedizin
2016 Zusatzbezeichnung genetische Beratung
2016 Funktionsoberarzt für Urologie des Uniklinikums Köln
2017-2020 Oberarzt und Sektionsleiter Endourologie des Uniklinikums Köln
2017 Zusatzbezeichnung Medikamentöse Tumortherapie
2019 Habilitation / Lehrkörper der Medizinischen Fakultät zu Köln
2020 Gesellschafter der urologischen Gemeinschaftspraxis CUROS
Grabbert M, Khoder WY, Gratzke C, Paffenholz P, Salem J*, Bauer RM*.
Comprehensive analysis of Twitter activity on #Incontinence.
Neurourol Urodyn. 2020 Jan;39(1):440-446.
Funke T, von Brandenstein M, Paffenholz P, Köditz B, Nestler T, Herden J, Montesinos-Rongen M, Isachenko E, Rahimi G, Fries JWU, Heidenreich A, Salem J.
Vimentin 3 Allows Differentiation between Normozoospermia and Oligoasthenoteratozoospermia.
Dis Markers. 2019 Dec 10;2019:9803498.
Mund E, Salem J, Kreipe HH, Hussein K.
Clinically latent and autopsy-verified inflammatory disorders and malignant tumours in transplant patients.
J Clin Pathol. 2020 Dec 28:jclinpath-2020-207080.
Reimer RP, Salem J, Merkt M, Sonnabend K, Lennartz S, Zopfs D, Heidenreich A, Maintz D, Haneder S, Große Hokamp N.
Size and volume of kidney stones in computed tomography: Influence of acquisition techniques and image reconstruction parameters.
Eur J Radiol. 2020 Nov;132:109267.
Hein S, Wilhelm K, Miernik A, Schoenthaler M, Suarez-Ibarrola R, Gratzke C, Salem J, Karapanos L, Netsch C, Becker B, Secker A, Veser J, Neisius A, Fritsche HM, Schnabel MJ.
Radiation exposure during retrograde intrarenal surgery (RIRS): a prospective multicenter evaluation.
World J Urol. 2021 Jan;39(1):217-224.
Paffenholz P, Votteler S, Nazari S, Nestler T, Salem J, Grabbert M, von Brandenstein M, Loosen SH, Zey S, Heidenreich A, Herden J, Denil J.
Efficacy of the Oestrogen Antagonist Tamoxifen on Sperm Parameters in Patients with Idiopathic Oligoathenoteratozoospermia.
Urol Int. 2019;103(1):108-115.
Paffenholz P, Grein K, Heidegger I, Nestler T, Grabbert M, Salem J, Hellmich M, Pfister D, Heidenreich A.
Predictors of thrombosis in testicular cancer during platinum-based chemotherapy.
World J Urol. 2019 Sep;37(9):1907-1916.
Große Hokamp N, Lennartz S, Salem J, Pinto Dos Santos D, Heidenreich A, Maintz D, Haneder S.
Dose independent characterization of renal stones by means of dual energy computed tomography and machine learning: an ex-vivo study.
Eur Radiol. 2020 Mar;30(3):1397-1404.
Struck JP, Stahl L, Braun M, Homberg R, Schönberger M, Westphal J, Salem J.
The working time load of specialists and senior physicians in German urology-a critical assessment.
Urologe A. 2019 Aug;58(8):918-923.
Chang DH, Slebocki K, Khristenko E, Herden J, Salem J, Große Hokamp N, Mammadov K, Hellmich M, Kabbasch C.
Low-dose computed tomography of urolithiasis in obese patients: a feasibility study to evaluate image reconstruction algorithms.
Diabetes Metab Syndr Obes. 2019 Apr 5;12:439-445.
Paffenholz P, Votteler S, Nazari S, Nestler T, Salem J, Grabbert M, von Brandenstein M, Loosen SH, Zey S, Heidenreich A, Herden J, Denil J.
Efficacy of the Oestrogen Antagonist Tamoxifen on Sperm Parameters in Patients with Idiopathic Oligoathenoteratozoospermia.
Urol Int. 2019;103(1):108-115.
Paffenholz P, Grein K, Heidegger I, Nestler T, Grabbert M, Salem J, Hellmich M, Pfister D, Heidenreich A.
Predictors of thrombosis in testicular cancer during platinum-based chemotherapy.
World J Urol. 2018 Dec 13.
Große Hokamp N, Salem J, Hesse A, Holz JA, Ritter M, Heidenreich A, Maintz D, Haneder S.
Low-Dose Characterization of Kidney Stones Using Spectral Detector Computed Tomography: An Ex Vivo Study.
Invest Radiol. 2018 Aug;53(8):457-462.
Struck JP, Siegel F, Kramer MW, Tsaur I, Heidenreich A, Haferkamp A, Merseburger AS, Salem J*, Borgmann H*.
Substantial utilization of Facebook, Twitter, YouTube, and Instagram in the prostate cancer community.
World J Urol. 2018 Aug;36(8):1241-1246.
Borgmann H, Arnold HK, Meyer CP, Bründl J, König J, Nestler T, Ruf C, Struck J, Salem J.
Training, Research, and Working Conditions for Urology Residents in Germany: A Contemporary Survey.
Eur Urol Focus. 2018 Apr;4(3):455-460.
Dogan S, Hennig M, Frank T, Struck JP, Cebulla A, Salem J, Borgmann H, Klatte T, Merseburger AS, Kramer M, Hofbauer SL.
Acceptance of Adjuvant and Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer in Germany: A Survey of Current Practice.
Urol Int. 2018 Mar 6.
Salem J*, Paffenholz P*, Bolenz C, von Brandenstein M, Cebulla A, Haferkamp A, Kuru TH, Lee CT, Pfister D, Tsaur I, Borgmann H, Heidenreich A.
Websites on Bladder Cancer: An Appropriate Source of Patient Information?
J Cancer Educ. 2018 Jan 8.
Borgmann H*, Salem J*, Boehm K, Groeben C, Schmid M, Siegel FP, Baunacke M, Huber J
Mapping the Landscape of Urology: A New Media-Based Cross-Sectional Analysis of Public Versus Academic Interest.
Int J Urol. 2018 Mar 8.
Salem J*, Borgmann H*, Baunacke M, Boehm K, Hanske J, MacNeily A, Meyer C, Nestler T, Schmid S, Huber J
Widespread use of Internet and Apps in professional life of urology residents.
Can Urol Assoc J 2017;11(9):E355-66.
Paffenholz P*, Salem J*, Borgmann H, Nestler T, Pfister D, Ruf C, Tsaur T, Haferkamp A, Heidenreich A
Testicular cancer on the web – An appropriate source of patient information in concordance with the European Association of Urology Guidelines?
J Cancer Educ. 2017 Aug 4.
Baunacke M, Groeben C, Borgmann H, Salem J, Kliesch S, Huber J.
Andrology on the internet: most wanted, controversial, and often primary source of information for patients.
Andrologia. 2017 Aug 25.
Borgmann H, Bründl J, Huber J, Ruf C, Schagdarsurgengin U, Wullich B, Salem J.
Prerequisites, skills and productivity of young academic urologists in Germany.
Urologe A. 2017 Dec;56(12):1603-1610.
Rosenbaum CM, Reiss CP, Borgmann H, Salem J, Fisch M, Huber J, Schmid M, Ahyai SA.
Management of Anterior Urethral Strictures in Adults: A Survey of Contemporary Practice in Germany.
Urol Int. 2017;99(1):43-50.
Schapoor H*, Salem J*, Bechara F, Haferkamp A, Heidenreich A, Paffenholz P, Sand M, Tsaur I, Borgmann H.
Hidradenitis suppurativa gains increasing interest on Web: a source for patient information?
Int J Dermatol. 2017 Jul;56(7):726-732.
Salem J*, Borgmann H*, MacNeily A, Boehm K, Schmid M, Groeben C, Baunacke M, Huber J.
New Media for Educating Urology Residents: An Interview Study in Canada and Germany.
J Surg Educ. 2017 May – Jun;74(3):495-502.
Borgmann H, Rodríguez Socarrás M, Salem J, Tsaur I, Gomez Rivas J, Barret E, Tortolero L.
Feasibility and safety of augmented reality-assisted urological surgery using smartglass.
World J Urol. 2017 Jun;35(6):967-972.
Selinski S, Gerullis H, Otto T, Roth E, Volkert F, Ovsiannikov D, Salem J, Moormann O, Geis BC, Niedner H, Blaszkewicz M, Hengstler JG, Golka K.
Ultra-slow N-Acetyltransferase 2 Is Associated with Recurrence-free Time in Bladder Cancer Patients.
Eur Urol. 2016 Dec 28. (research letter)
Salem J*, Borgmann H*, Bultitude M, Fritsche HM, Haferkamp A, Heidenreich A, Miernik A, Neisius A, Knoll T, Thomas C, Tsaur I.
Online Discussion on #KidneyStones: A Longitudinal Assessment of Activity, Users and Content.
PLoS One. 2016 Aug 18;11(8).
Salem J*, Borgmann H*, Bründl J, Lausenmeyer EM, Lent V, Schroeder A, Heidenreich A.
Residents training in private practice: Conflicts between circumstances, willingness, and reality.
Urologe A. 2016 Aug;55(8):1062-70.
Borgmann H, Loeb S, Salem J, Thomas C, Haferkamp A, Murphy DG, Tsaur I.
Activity, content, contributors, and influencers of the twitter discussion on urologic oncology.
Urol Oncol. 2016 Mar 29.
Link
Borgmann H, Woelm JH, Merseburger A, Nestler T, Salem J, Brandt MP, Haferkamp A, Loeb S.
Qualitative Twitter analysis of participants, tweet strategies, and tweet content at a major urologic conference.
Can Urol Assoc J. 2016 Jan-Feb;10(1-2):39-44.
Link
Borgmann H, Mager R, Salem J, Bründl J, Kunath F, Thomas C, Haferkamp A, Tsaur I.
Robotic Prostatectomy on the Web: A Cross-Sectional Qualitative Assessment.
Clin Genitourin Cancer. 2015 Dec 23.
Link
Borgmann H, Wölm JH, Vallo S, Mager R, Huber J, Breyer J, Salem J, Loeb S, Haferkamp A, Tsaur I.
Prostate Cancer on the Web-Expedient Tool for Patients‘ Decision-Making?
J Cancer Educ. 2015; Aug 4.
Link
Abbas M, Salem J, Stucki-Koch A, Rickmann M, Grünwald V, Herrmann T, Jonigk D, Kreipe H, Hussein K.
Expression of angiogenic factors is increased in metastasised renal cell carcinomas.
Virchows Arch. 2014;464:197-202.
1994-2006 Ausbildung zum Internisten und Altersmediziner am Klinikum Nürnberg, Medizinische Klinik 2 mit Lehrstuhl für Innere Medizin – Geriatrie der FAU Erlangen-Nürnberg
2009-2010 Advanced Postgraduate Course an der European Academy for Medicine of Ageing (EAMA)
2007-2010 Masterstudiengang mit Abschluss zum MHBA (Master of Health Business Administration) an der FAU Erlangen-Nürnberg, Lehrstuhl für Gesundheitsmanagement
2004-2012 Funktionsoberarzt und Oberarzt Medizinische Klinik 2 – Geriatrie, Klinikum Nürnberg
1/2013-7/2013 Leitender Oberarzt Medizinische Klinik 2 – Geriatrie, Klinikum Nürnberg
8/2013- 9/2019 Chefarzt der Abteilung Akutgeriatrie mit Tagesklinik und ambulanter geriatrischer Rehabilitation am Helios Hanseklinikum Stralsund
Seit 11/2019 Chefarzt Klinik Wartenberg, Allgemeine und Geriatrische Rehabilitation
Becher KF, Madersbacher S, Michel MC, Olbert P.
Management of geriatric patients with benign prostatic hyperplasia.
Urologe A. 2020 Oct;59(10):1195-1203. doi: 10.1007/s00120-020-01311-9. PMID: 32880664 Review. German.
Becher KF, Wiedemann A
Summary of diagnostic and therapy of uncomplicated urinary tract infections.
MMW Fortschr Med. 2019 Sep;161(16):58-65. doi: 10.1007/s15006-019-0025-7.PMID: 31556072 Review. German.
Becher K, Bojack B, Ege S, von der Heide S, Kirschner-Hermanns R, Wiedemann A
Urinary incontinence in geriatric patients: behavioral therapy, toilet training and physiotherapy.
Aktuelle Urol. 2019 Sep;50(5):524-537. doi: 10.1055/a-0914-8113. Epub 2019 Aug 29. PMID: 31466099 German.
Muderrisoglu AE, Becher KF, Madersbacher S, Michel MC
Cognitive and mood side effects of lower urinary tract medication.
Expert Opin Drug Saf. 2019 Oct;18(10):915-923. doi: 10.1080/14740338.2019.1652269. Epub 2019 Aug 8. PMID: 31373245 Review.
Becher KF
Delirium in geriatric urology patients.
Urologe A. 2019 Apr;58(4):398-402. doi: 10.1007/s00120-019-0887-4. PMID: 30859233 Review. German.
Becher KF, Madersbacher S, Michel MC
Do benign prostatic hyperplasia drugs affect mood or cognition?
Urologe A. 2019 Mar;58(3):248-253. doi: 10.1007/s00120-019-0871-z. PMID: 30762077 Review. German.
Becher KF
Urinary incontinence – Diagnostic and therapy options in the elderly.
MMW Fortschr Med. 2019 Feb;161(2):37-42. doi: 10.1007/s15006-019-0130-7. PMID: 30721492 Review. German.
Becher KF, Nitschmann S
Prevention of catheter-associated urinary tract infections.
Internist (Berl). 2017 Jan;58(1):100-102. doi: 10.1007/s00108-016-0158-z.PMID: 27837224 German.
Becher KF
Pharmacotherapy of urinary incontinence in the elderly.
Internist (Berl). 2016 Apr;57(4):390-8. doi: 10.1007/s00108-016-0026-x. PMID: 26886709 German.
Becher KF, Klempien I, Wiedemann A
Urinary tract infections in the elderly.
Z Gerontol Geriatr. 2015 Oct;48(7):588-94. doi: 10.1007/s00391-015-0947-3. Epub 2015 Aug 29. PMID: 26318186 Review. German.
Oelke M, Becher K, Castro-Diaz D, Chartier-Kastler E, Kirby M, Wagg A, Wehling M
Appropriateness of oral drugs for long-term treatment of lower urinary tract symptoms in older persons: results of a systematic literature review and international consensus validation process (LUTS-FORTA 2014).
Age Ageing. 2015 Sep;44(5):745-55. doi: 10.1093/ageing/afv077. Epub 2015 Jun 23. PMID: 26104505 Free PMC article. Review.
Becher K, Oelke M, Grass-Kapanke B, Flohr J, Mueller EA, Papenkordt U, Schulte-Frei B, Steinwachs KC, Süss S, Wehling M
Improving the health care of geriatric patients: management of urinary incontinence: a position paper.
Z Gerontol Geriatr. 2013 Jul;46(5):456-64. doi: 10.1007/s00391-013-0491-y. PMID: 23619707 Review.
1978-1894 und 1988-1990 Klinik und Poliklinik für Urologie der Universität Leipzig
1982 Facharzt für Urologie (Urologische Klinik Universität Leipzig),
1983 Promotion (Universität Leipzig),
1987 Facharzt für Chirurgie (Chirurgische Klinik Universität Leipzig)
1990-2001 Urologische Klinik der Medizinischen Hochschule Hannover
1991 Habilitation (Universität Leipzig und Medizinische Hochschule Hannover),
1995 Professur (Medizinische Hochschule Hannover)
2001-2017 Chefarzt Urologische Klinik, Evang. Krankenhaus Oberhausen
Seit 2017 Senior Consultant Urologische Klinik, Evang. Krankenhaus Oberhausen
Höfner K, Stief Ch, Jonas U (Hrsg.)
Benigne Prostatahyperplasie – Leitfaden für die Praxis.
Springer, Berlin Heidelberg New York, 2000
Höfner K (1999)
alpha (1)-Blocker therapy in the nineties: focus on the disease.
Prostate cancer and prostatic diseases 2: S9-S15.
link
Höfner K, Claes H, De Reijke TM
et al. (1999) Tamsulosin 0.4 mg once daily: effect on sexual function in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.
European urology 36:335-341.
link
Höfner K, Jonas U (2002)
Alfuzosin: a clinically uroselective alpha1-blocker.
World journal of urology 19:405-412.
link
Höfner K,Deutsche Gesellschaft für Urologie (2004)
Diagnostik der Obstruktion des unteren Harntraktes beim Mann. Leitlinien der Deutschen Gesellschaft für Urologie.
Der Urologe. Ausg. A 43:1301-1305.
link
Höfner K, Tunn U-W, Reich O, Rübben H (2007)
Operative Therapie des benignen Prostatasyndroms.
Deutsches Ärzteblatt 104: 2424-2429
Höfner K (2008)
Bewegung in Sachen BPS.
Der Urologe. Ausg. A 47:139-140.
link
Höfner K, Oelke M (2009)
Kombinationstherapie bei LUTS: Wann Pillen und wann nicht?
Der Urologe. Ausg. A 48:250-256.
link
Höfner K, Bach T, Berges R et al. (2016)
S2e-Leitlinie der Deutschen Urologen: Konservative und medikamentöse Therapie des benignen Prostatasyndroms.
Der Urologe. Ausg. A 55:184-194.
link
Höfner K, Ulrich S, Berges R (2017)
Kombinationsbehandlung des BPS mit Tamsulosin und Finasterid: Literaturübersicht und Verordnungsdaten.
Der Urologe. Ausg. A 56:645-653.
link
31.12.1968 BESTALLUNG ALS ARZT
01.01.1969-01.04.1970 OBERARZT DER CHIRURGISCHEN ABTEILUNG des Stadt- und Kreiskrankenhauses in Fredericia/Dänemark
16.04.1970 BEGINN DER UROLOGISCHEN FACHAUSBILDUNG an der Urologischen Abteilung des Chirurgischen Zentrums der Universität Heidelberg (Direktor: Professor Dr. med. L. Röhl)
06.06.1973 ANERKENNUNG ALS ARZT FÜR UROLOGIE durch die Landesärztekammer Baden-Württemberg
12.07.1973 VENIA LEGENDI für das Fach Urologie Habilitationsschrift: „Experimentelle und klinische Erfahrungen bei der Konservierung von Spendernieren“.
April 1973-28.02.1994 ZWEITER OBERARZT DER UROLOGISCHEN ABTEILUNG des Chirurgischen Zentrums der Universität Heidelberg
01.03.1974-31.10.1986 LEITENDER OBERARZT DER UROLOGISCHEN ABTEILUNG des Chirurgischen Zentrums der Universität Heidelberg und STELLVERTRETER DES DIREKTORS DER ABTEILUNG FÜR UROLOGIE
18.11.1977 ERNENNUNG ZUM AUSSERPLANMÄSSIGEN PROFESSOR durch das Kultusministerium Baden-Württemberg
04.06.1980 ERNENNUNG ZUM PROFESSOR (C2) und Verleihung der Eigenschaft eines Beamten auf Lebenszeit
01.11.1986-30.09.2007 DIREKTOR DER UROLOGISCHEN KLINIK des Zentralkrankenhauses St.-Jürgen-Straße in Bremen, Akademisches Lehrkrankenhaus der Universität Göttingen
EINTRITT IN DEN RUHESTAND
2008-2020 Praxistätigkeit im Urologicum Bremen
[Idiopathic retroperitoneal fibrosis. A case with acute anuria in a patient with bilateral double kidney].
Dreikorn K, Jensen F.Ugeskr Laeger. 1970 Jul 30;132(31):1431-6.PMID: 5450798 Danish.
Complementary and alternative medicine in urology.
Dreikorn K, BJU Int. 2005 Dec;96(8):1177-84. doi: 10.1111/j.1464-410X.2005.05931.x.PMID: 16285876 Review.
[Status of phytotherapeutic drugs in treatment of benign prostatic hyperplasia].
Dreikorn K, Schönhöfer PS.Urologe A. 1995 Mar;34(2):119-29.PMID: 7538709 Review. German.
[Conservative, non-hormonal treatment of benign prostatic hyperplasia].
Dreikorn K, Richter R, Schönhöfer PS. Urologe A. 1990 Jan;29(1):8-16; discussion 17-8.PMID: 1690486 Review. German.
[Organ preservation].
Dreikorn K, Zentralbl Chir. 1992;117(12):642-7.PMID: 1285469 Review. German.
Problems of the distal ureter in renal transplantation.
Dreikorn K, Urol Int. 1992;49(2):76-89. doi: 10.1159/000282399.PMID: 1441016 Review
[Phytotherapy for BPS. Which products can still be prescribed?].
Madersbacher S, Schatzl G, Brössner C, Dreikorn K, Urologe A. 2005 May;44(5):513-20. doi: 10.1007/s00120-005-0778-8.PMID: 15726313 Review. German
[Phytotherapy of benign prostatic hyperplasia. Current evidence-based evaluation].
Dreikorn K, Berges R, Pientka L, Jonas U.Urologe A. 2002 Sep;41(5):447-51. doi: 10.1007/s00120-002-0234-y.PMID: 12426861 Review. German
Phytotherapeutic agents in the treatment of benign prostatic hyperplasia.
Dreikorn K. Curr Urol Rep. 2000 Aug;1(2):103-9. doi: 10.1007/s11934-000-0044-y.PMID: 12084323 Review.
Review of recent placebo-controlled trials utilizing phytotherapeutic agents for treatment of BPH.
Lowe FC, Dreikorn K, Borkowski A, Braeckman J, Denis L, Ferrari P, Gerber G, Levin R, Perrin P, Senge T.Prostate. 1998 Nov 1;37(3):187-93. doi: 10.1002/(sici)1097-0045(19981101)37:3<187::aid-pros8>3.0.co;2-t.PMID: 9792136 Review
The role of phytotherapy in treating lower urinary tract symptoms and benign prostatic hyperplasia.
Dreikorn K,World J Urol. 2002 Apr;19(6):426-35. doi: 10.1007/s00345-002-0247-6.PMID: 12022711 Review
Kidney transplantation in urology. Past–present–future].
Schubert J, Dreikorn K, Seiter H, Huland H, Jonas D, Kälble T, Wolf G, Steiner T.Urologe A. 2006 Sep;45 Suppl 4:85-9. doi: 10.1007/s00120-006-1110-y.PMID: 16821057 German.
[Kidney transplantation].
Dreikorn K,Urologe A. 1994 Sep;33(5):359.PMID: 7974921 German.
[S2e guideline of the German urologists: Instrumental treatment of benign prostatic hyperplasia].
Bschleipfer T, Bach T, Berges R, Dreikorn K, Gratzke C, Madersbacher S, Michel MS, Muschter R, Oelke M, Reich O, Tschuschke C, Höfner K.Urologe A. 2016 Feb;55(2):195-207. doi: 10.1007/s00120-015-3983-0.
[S2e guideline of the German urologists: Conservative and pharmacologic treatment of benign prostatic hyperplasia].Höfner K, Bach T, Berges R, Dreikorn K, Gratzke C, Madersbacher S, Michel MS, Muschter R, Oelke M, Reich O, Tschuschke C, Bschleipfer T.Urologe A. 2016 Feb;55(2):184-94. doi: 10.1007/s00120-015-3984-z.PMID: 26518303 German
[The 27th annual meeting of the working group kidney transplantation of the German Society for Urology : November 21-24, 2019 in Halle (Saale)].
Weigand K, Friedersdorff F, Apel H, Stöckle M, Putz J, Dreikorn K, Giessing M, Fornara P.Urologe A. 2020 Jan;59(1):84-86. doi: 10.1007/s00120-019-01099-3.PMID: 31863130 German.
[Report of the 23rd annual meeting of the Working Group Kidney Transplantation of the German Society of Urology in Homburg (Saar)].
Janssen M, Putz J, Giessing M, Fornara P, Friedersdorff F, Dreikorn K, Heynemann H, Stein K, Wunderlich H, Stöckle M.Urologe A. 2017 Jan;56(1):69-71. doi: 10.1007/s00120-016-0295-y.PMID: 27966097 German.
[Phytotherapy of benign prostate syndrome and prostate cancer: better than placebo].
Wehrberger C, Dreikorn K, Jensen F.Ugeskr Laeger. Schmitz-Dräger BJ, Oelke M, Madersbacher S.Urologe A. 2012 Dec;51(12):1674-82. doi: 10.1007/s00120-012-3033-0.PMID: 23160605 German
Technique of kidney transplantation].
Höppner W, Dreikorn K, Jensen F.Ugeskr Laeger. Urologe A. 1994 Jul;33(4):347-58.PMID: 7941184 Review. German.
Urological de novo malignancy after kidney transplantation: a case for the urologist.
Melchior S, Franzaring L, Shardan A, Schwenke C, Plümpe A, Schnell R, Dreikorn K, J Urol. 2011 Feb;185(2):428-32. doi: 10.1016/j.juro.2010.09.091. Epub 2010 Dec 17.PMID: 21167532
Medical management of benign prostatic hyperplasia other than with hormones or alpha blockers.
Fitzpatrick JM, Dreikorn K, Habib F, Mebust WK, Perrin P, Schulze HK.Prog Clin Biol Res. 1994;386:303-9.PMID: 7528399 Review.
[Therapy of benign prostate syndrome (BPS): guidelines of the German Urologists (DGU)].
Berges R, Dreikorn K, Höfner K, Madersbacher S, Michel MC, Muschter R, Oelke M, Reich O, Rulf W, Tschuschke C, Tunn U; Society of German Urologists.Urologe A. 2009 Dec;48(12):1503-16. doi: 10.1007/s00120-009-2067-4.PMID: 19756467 German.
[18th Annual Congress of the Renal Transplantation Working Group of the German Society of Urology: Würzburg, 18-20 November 2010].
Kocot A, Giessing M, Fornara P, Engehausen D, Heynemann H, Wunderlich H, Dreikorn K, Riedmiller H.Urologe A. 2011 Jul;50(7):846-9. doi: 10.1007/s00120-011-2600-0.PMID: 21678106 German.
[Guidelines of German urologists on therapy of benign prostate syndrome].
Berges R, Dreikorn K, Höfner K, Jonas U, Laval KU, Madersbacher S, Michel MC, Muschter R, Oelke M, Pientka L, Tschuschke C, Tunn U, Palmtag H, Goepel M, Schalhhäuser K, Göckeel-Beining B, Heidenreich A, Rübben H, Schalkerhäuser K, Thon W, Thüroff J, Weidner W; DGU-Leitlinienkommission.Urologe A. 2003 May;42(5):722-38. doi: 10.1007/s00120-003-0318-3. Epub 2003 Mar 22.PMID: 12750807 German.
[The 2018 annual report on the 26th annual meeting of the working group for kidney transplantation of the German Society of Urology in Berlin].
Friedersdorff F, Putz J, Dreikorn K, Giessing M, Fornara P, Stöckle M, Schlomm T.Urologe A. 2019 Mar;58(3):324-328. doi: 10.1007/s00120-019-0873-x.PMID: 30762078 German.
[Contemporary medical management of the benign prostatic syndrome].
Madersbacher S, Michel MC, Dreikorn K. Urologe A. 2008 Feb;47(2):166-71. doi: 10.1007/s00120-007-1613-1.PMID: 18210072 Review. German.
Risk factors for disease progression in patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH): a systematic analysis of expert opinion.
Lowe FC, Batista J, Berges R, Chartier-Kastler E, Conti G, Desgrandchamps F, Dreikorn K, O’Leary M, Perez M, Speakman M, Trachtenberg J, Tubaro A, Meesen B, Smets L, Stoevelaar H.Prostate Cancer Prostatic Dis. 2005;8(3):206-9. doi: 10.1038/sj.pcan.4500806.PMID: 15953934
Gender-specific effects of NAT2 and GSTM1 in bladder cancer.
Schnakenberg E, Lustig M, Breuer R, Werdin R, Hübotter R, Dreikorn K, Schloot W.Clin Genet. 2000 Apr;57(4):270-7. doi: 10.1034/j.1399-0004.2000.570405.x.PMID: 10845567
Hypertension following renal transplantation (author’s transl)].
Tschöpe W, Ritz E, Horsch R, Dreikorn K. Urologe A. 1981 May;20(3):141-4.PMID: 7022997 Review. German
Rapid turnover of the AMP-adenosine metabolic cycle in the guinea pig heart.
Kroll K, Decking UK, Dreikorn K, Schrader J.Circ Res. 1993 Nov;73(5):846-56. doi: 10.1161/01.res.73.5.846.PMID: 8403255
Technique of multiple organ procurement. Is involvement of urology indicated?].
Höppner W, Dreikorn K. Urologe A. 1998 Jul;37(4):395-9. doi: 10.1007/s001200050197.PMID: 9738292 German
[Kidney transplantation in the Federal Republic of Germany today].
Dreikorn K, Ritz E, Röhl L, Lenhard V, Gurland HJ.Dtsch Med Wochenschr. 1976 Oct 8;101(41):1498-504. doi: 10.1055/s-0028-1104300.PMID: 786580 Review. German.
Susceptibility genes: GSTM1 and GSTM3 as genetic risk factors in bladder cancer.
Schnakenberg E, Breuer R, Werdin R, Dreikorn K, Schloot W.Cytogenet Cell Genet. 2000;91(1-4):234-8. doi: 10.1159/000056851.PMID: 11173863
48- to 96-hour preservation of canine kidneys by initial perfusion and hypothermic storage using the Euro-Collins solution.
Dreikorn K, Horsch R, Röhl L.Eur Urol. 1980;6(4):221-4. doi: 10.1159/000473336.PMID: 6993210
[Report of the 24th annual conference of the Working Group Kidney Transplantation of the German Society of Urology in Erlangen].
Apel H, Putz J, Fornara P, Friedersdorff F, Dreikorn K, Stöckle M, Wullich B.Urologe A. 2017 Sep;56(9):1182-1184. doi: 10.1007/s00120-017-0452-y.PMID: 28681234 German.
Genotyping of the polymorphic N-acetyltransferase (NAT2) and loss of heterozygosity in bladder cancer patients.
Schnakenberg E, Ehlers C, Feyerabend W, Werdin R, Hübotter R, Dreikorn K, Schloot W.Clin Genet. 1998 May;53(5):396-402. doi: 10.1111/j.1399-0004.1998.tb02753.x.PMID: 9660060
Efficacy and safety of propiverine in SCI-patients suffering from detrusor hyperreflexia–a double-blind, placebo-controlled clinical trial.
Stöhrer M, Madersbacher H, Richter R, Wehnert J, Dreikorn K. Spinal Cord. 1999 Mar;37(3):196-200. doi: 10.1038/sj.sc.3100750.PMID: 10213329 Clinical Trial.
Technetium-99m labeled renal function and imaging agents: II. Clinical evaluation of 99mTc MAG3 (99mTc mercaptoacetylglycylglycylglycine).
Bubeck B, Brandau W, Steinbächer M, Reinbold F, Dreikorn K, Eisenhut M, Georgi P.Int J Rad Appl Instrum B. 1988;15(1):109-18. doi: 10.1016/0883-2897(88)90166-3.PMID: 2965116
[Kidney transplantation: Quo vadis?].
Giessing M, Dreikorn K. Urologe A. 2009 Dec;48(12):1427-8. doi: 10.1007/s00120-009-2154-6.PMID: 19953355 German.
[Recent perspectives on the mechanisms of rejection in kidney transplantation (author’s transl)].
Lenhard V, Resch K, Dreikorn K, Ritz E.Klin Wochenschr. 1978 Jan 15;56(2):51-60. doi: 10.1007/BF01480084.PMID: 342812 Review. German.
Urodynamic studies in prune belly syndrome. A case report.
Palmtag H, Dreikorn K, Röhl L.Scand J Urol Nephrol. 1979;13(1):11-6. doi: 10.3109/00365597909179994.PMID: 33448
[Diagnostic and differential diagnosis of benign prostate syndrome (BPS): guidelines of the German Urologists].
Berges R, Dreikorn K, Höfner K, Madersbacher S, Michel MC, Muschter R, Oelke M, Reich O, Rulf W, Tschuschke C, Tunn U.Urologe A. 2009 Nov;48(11):1356-60, 1362-4. doi: 10.1007/s00120-009-2066-5.PMID: 19756468 German.
[The 20th annual conference of the Working Group on Kidney Transplantation of the Academy of German Urologists in Aachen].
Brehmer B, Kauffmann C, Giessing M, Fornara P, Engehausen D, Wunderlich H, Heynemann H, Dreikorn K, Heidenreich A.Urologe A. 2013 Apr;52(4):580-3. doi: 10.1007/s00120-013-3154-0.PMID: 23483274 German.
[Kidney transplantation 1987].
Dreikorn K, Krankenpfl J. 1987 Oct;25(10):111-8.PMID: 3320508 German.
[Treatment of renal vasospasm in shock (author’s transl)].
Dreikorn K, Beduhn D.Urol Int. 1973;28(3):206-12. doi: 10.1159/000279848.PMID: 4584961 German.
[19th annual conference of the working group on kidney transplantation of the academy of german urologists : mainz, 10-12 november 2011].
Mehralivand S, Giessing M, Fornara P, Engehausen D, Heynemann H, Wunderlich H, Dreikorn K, Thüroff JW, Stein R.Urologe A. 2012 Apr;51(4):550-4. doi: 10.1007/s00120-012-2848-z.PMID: 22437445 German
[Guidelines for German urologists on diagnosis of benign prostate syndrome].
Berges R, Dreikorn K, Höfner K, Jonas U, Laval KU, Madersbacher S, Michel MC, Muschter R, Oelke M, Pientka L, Tschuschke C, Tunn U, Schalkhäuser K, Göckel-Beining B, Heidenreich A, Rübben H, Schalkhäuser K, Thon W, Thüroff J, Weidner W; Arbeitskreis Urologische Funktionsdiagnostik und Urologie der Frau; Arbeitskreis BPH; BDU; DGU-Leitlinienkommission.Urologe A. 2003 Apr;42(4):584-90. doi: 10.1007/s00120-003-0319-2. Epub 2003 Mar 12.PMID: 12715130 German.
[Surgical-urologic complications after kidney transplantation].
Dreikorn K, Horsch R, Rössler W.Urologe A. 1982 Sep;21(5):256-64.PMID: 6758277 German.
Complete regression of multiple pulmonary metastases in a patient with advanced renal cell carcinoma treated by occlusion of the renal artery with subsequent radical nephrectomy and progesterone.
Dreikorn K, Terwey B, Drings P, Horsch R, Palmtag H, Rössler W.Eur Urol. 1983;9(4):254-6. doi: 10.1159/000474095.PMID: 6223820
Integrating risk profiles for disease progression in the treatment choice for patients with lower urinary tract symptoms/benign prostatic hyperplasia: a combined analysis of external evidence and clinical expertise.
Speakman M, Batista J, Berges R, Chartier-Kastler E, Conti G, Desgrandchamps F, Dreikorn K, Lowe F, O’Leary M, Perez M, Trachtenberg J, Tubaro A, Meesen B, Smets L, Stoevelaar H.Prostate Cancer Prostatic Dis. 2005;8(4):369-74. doi: 10.1038/sj.pcan.4500827.PMID: 16130013
Angiographic evaluation of machine perfused kidneys.
Dreikorn K.Urol Res. 1975 Oct 29;3(3):123-7. doi: 10.1007/BF00256033.PMID: 1103416
Assessment of plasma neopterin in clinical kidney transplantation.
Schäfer AJ, Daniel V, Dreikorn K, Opelz G.Transplantation. 1986 Apr;41(4):454-9. doi: 10.1097/00007890-198604000-00008.PMID: 3515644
[Current immunologic aspects of kidney transplantation].
Lenhard V, Dreikorn K, Opelz G.Urologe A. 1982 Sep;21(5):280-9.PMID: 6758280 German.
Renal perfusion and mean vascular transit time.
Schmidlin P, Clorius JH, Lubosch EM, Siems H, Boehm M, Dreikorn K. Eur J Nucl Med. 1985;11(2-3):69-72. doi: 10.1007/BF00252136.PMID: 3899660
[Kidney transplantation in children].
Müller-Wiefel DE, Schindera F, Niggemann B, Dreikorn K, Halbfass H, Mehls O, Michalk D, Klare B, Schärer K.Fortschr Med. 1979 Nov 15;97(43):1951-7.PMID: 389767 German
Renal graft evaluation with pertechnetate and I-131 Hippuran. A comparative clinical study.
Clorius JH, Dreikorn K, Zelt J, Raptou E, Weber D, Rubinstein K, Dahm D, Georgi P.J Nucl Med. 1979 Oct;20(10):1029-37.PMID: 395278
Long-term results in children following dialysis and renal transplantation.
Röhl L, Dreikorn K, Schüler HW, Asbach HW, Horsch R, Löbelenz J, Lenhard V.Proc Eur Dial Transplant Assoc. 1978;15:322-9.PMID: 368779
Renal cell carcinoma in a transplanted kidney: successful organ-preserving procedure.
Höppner W, Grosse K, Dreikorn K. Urol Int. 1996;56(2):110-1. doi: 10.1159/000282823.PMID: 865900
HLA-DR-MT matching improves graft survival rate in cadaver kidney transplantation. A prospective multicenter analysis of the South German Cooperative Study Group for Kidney Transplantation.
Müller GA, Müller C, Bockhorn H, Lenhard V, Dreikorn K, Fetta RF, Wilms H, Fassbinder W, Gumbel B, Albert FW, Ewald RW, Goldmann S, Sprenger-Klasen I, Franz HE, Wernet P.Klin Wochenschr. 1983 Jan 3;61(1):17-23. doi: 10.1007/BF01484435.PMID: 6187967
Surgical treatment of acute epididymitis and its underlying diseases.
Höppner W, Strohmeyer T, Hartmann M, Lopez-Gamarra D, Dreikorn K. Eur Urol. 1992;22(3):218-21. doi: 10.1159/000474759.PMID: 1468479
[Urologic tumors and organ transplantation. Recommendations of the Kidney Transplantation Working Group of the Ongoing Graduate and Continuing Education Committee of the German Society of Urology].
Dreikorn K, Heicapell R, Heynemann H, Klebingat KJ, Reek C, Schönberger B, Seiter H, Wolff JM.Urologe A. 2001 Nov;40(6):493-4. doi: 10.1007/s001200170014.PMID: 11760358 German
Influence of Lewis and other blood group systems in kidney transplantation.
Lenhard V, Hansen B, Roelcke D, Dreikorn K, Wernet P, Bockhorn H, Fassbinder W, Fetta RF, Wilms H, Gumbel B, Albert FW, Ewald RW, Sprenger-Klasen I, Goldmann SF.Proc Eur Dial Transplant Assoc. 1983;19:432-7.PMID: 6348744
[Injuries of the lower urogenital tract in pelvic fractures and symphyseal ruptures].
Pfitzenmaier N, Mischkowsky T, Möhring K, Dreikorn K, Schneider E.Helv Chir Acta. 1983 Jun;50(3):235-42.PMID: 6629805 German.
[The 22nd annual meeting of the working group for kidney transplantation of the German Society of Urology in Rostock].
Putz J, Giessing M, Fornara P, Stöckle M, Friedersdorff F, Dreikorn K, Heynemann H, Wunderlich H, Stein K, Protzel C, Hakenberg OW.Urologe A. 2015 Oct;54(10):1429-32. doi: 10.1007/s00120-015-3948-3.PMID: 26459583 German.
Posture-induced disturbance of pertechnetate flow and I-123 iodohippurate transport in some renal graft recipients with hypertension.
Clorius JH, Dreikorn K, Zelt J, Schmidlin P, Raptou E, Georgi P.J Nucl Med. 1980 Sep;21(9):829-34.PMID: 6997440
Effect of immunomodulation following allogeneic blood transfusion on tumor neogenesis and growth–experimental studies in rats].
Scholler PM, Zeller WJ, Rössler W, Lenhard V, Weber E, Schmähl D, Dreikorn K. Arch Geschwulstforsch. 1987;57(2):81-90.PMID: 3592925 German
Prune belly syndrome: treatment of terminal renal failure by hemodialysis and renal transplantation.
Dreikorn K, Palmtag H, Röhl L.Eur Urol. 1977;3(4):245-7. doi: 10.1159/000472107.PMID: 21095
[Obstructive uropathy by perirenal lymphocele, a rare complication after renal transplantation (author’s transl)].
Dreikorn K. Urologe A. 1976 Sep;15(5):238-42.PMID: 788290
Antibody coating of urinary bacteria in transplanted patients.
Riedasch G, Ritz E, Dreikorn K, Andrassy K.Nephron. 1978;20(5):267-72. doi: 10.1159/000181234.PMID: 347321
[16th Annual Conference of the Working Group for Kidney Transplantation of the Academy of German Urologists. Bonn, 6th-8th November 2008].
Fechner G, Müller SC, Küster J, Dreikorn K, Steiner T, Giessing M.Urologe A. 2009 Mar;48(3):296-8. doi: 10.1007/s00120-009-1938-z.PMID: 19198797 German.
[Conservation of donated kidneys by machine].
Dreikorn K, Oertel A.Helv Chir Acta. 1973 Sep;40(4):489-95.PMID: 4584915 German.
[17th Annual Congress of the Kidney Transplantation Professional Circle of the German Society of Urology].
Trottmann M, Staehler M, Stadler T, Giessing M, Dreikorn K, Stief CG.Urologe A. 2007 Feb;46(2):170-1. doi: 10.1007/s00120-006-1270-9.PMID: 17211645 German.
Prognostic value of post-transplant hippurate scintigraphy.
Clorius JH, Dreikorn K, Schmidlin P, Orthgiess H.J Urol. 1983 May;129(5):920-4. doi: 10.1016/s0022-5347(17)52459-3.PMID: 6304356
[Report on the 17th Annual Congress of the Working Party on Renal Transplantation. Training and further education commission of German Urologists, Academy of German Urologists, Lübeck 12-14 November 2009].
Sommerauer M, Küster J, Steiner T, Dreikorn K, Heynemann H, Giessing M, Doehn C.Urologe A. 2010 May;49(5):655-8. doi: 10.1007/s00120-010-2228-5.PMID: 20182689 German. No abstract available.
[Therapy of terminal kidney failure through transplantation].
Dreikorn K, Röhl L.Dtsch Med Wochenschr. 1974 Oct 11;99(41):2043-6. doi: 10.1055/s-0028-1108089.PMID: 4154187 German.
Evaluation of scintigraphic data of renal transplants.
Schmidlin P, Clorius JH, Lubosch EM, Siems H, Dreikorn K. Comput Biomed Res. 1986 Aug;19(4):330-9. doi: 10.1016/0010-4809(86)90046-7.PMID: 3524983
Urological complications in renal transplantation.
Dreikorn K, Röhl L.Eur Urol. 1975;1(4):170-7.PMID: 786653
[Late prognosis of kidney transplantation in children].
Schärer K, Dreikorn K, Mehls O, Müller-Wiefel DE, Horsch R, Gretz N, Brittinger W.Z Kinderchir. 1985 Oct;40(5):260-2. doi: 10.1055/s-2008-1059789.PMID: 3907190 German.
Technetium-99m labeled renal function and imaging agents: I. Clinical evaluation of 99mTc CO2-DADS-A (99mTc N,N‘-bis-(mercaptoacetyl)-2,3-diaminopropanoate).
Bubeck B, Brandau W, Reinbold F, Dreikorn K, Steinbächer M, Eisenhut M, Georgi P.Int J Rad Appl Instrum B. 1988;15(1):99-108. doi: 10.1016/0883-2897(88)90165-1.PMID: 3127358
[Drugs in the treatment of benign prostatic hypertrophy. Reply].
Dreikorn K, Richter R, Schönhöfer PS.Urologe A. 1990 May;29(3):166-7.PMID: 1696413 Clinical Trial. German.
[Report of experiences with therapy of kidney injuries].
Palmtag H, Rössler W, Dreikorn K, Röhl L.Unfallchirurgie. 1983 Oct;9(5):260-7.PMID: 6649162 German.
[Experiences and data in sibling kidney transplantation (proceedings)].
Röhl L, Dreikorn K, Lenhard V, Ritz E.Z Immunitatsforsch Immunobiol. 1976 Dec;152(4):316-20.PMID: 795197 German.
[Indications for transplant nephrectomy with reference to possible complications].
Höppner W, Dreikorn K. Urologe A. 1995 Nov;34(6):485-8.PMID: 8848862 German
The Lewis antigen system and its relevance for clinical transplantation.
Fischer E, Lenhard V, Römer W, Dreikorn K, Schärer K, Roelcke D.Z Immunitatsforsch Immunobiol. 1979 Jun;155(5):420-3.PMID: 382664
[Conservative surgery of spontaneous rupture of renal grafts].
Dreikorn K, Horsch R, Röhl L.Helv Chir Acta. 1979 Aug;46(3):323-8.PMID: 385559 German
[„Kidney transplantation“ Professional Group of the Graduate and Continuing Education Committee of German Urologists. Report of the 10th annual meeting of the Professional Group 27 – 29 June 2002 in Halle/Saale].
Loertzer H, Heynemann H,Dreikorn K, Fornara P.Urologe A. 2003 Jan;42(1):113-6.PMID: 14655648 German.
[Treatment of ureteral obstruction and urinary fistulas after kidney transplantation].
Dreikorn K, Röhl L, Horsch R.Helv Chir Acta. 1979 Aug;46(3):357-64.PMID: 385561 German.
Percutaneous access for the correction of ureteral strictures after renal transplantation.
Dreikorn K. Transpl Int. 1989 Apr;2(1):40. doi: 10.1007/BF02425971.PMID: 2669804
Valve of ultrasonics in the diagnosis of postoperative functional disorders after kidney transplantation].
Dreikorn K, Kilian J, Heering H, van Kaick G, Röhl L.Helv Chir Acta. 1977 Jun;44(3):287-92.PMID: 361644 German.
[Organ preserving surgical treatment of solitary and bilateral renal tumors].
Röhl L, Dreikorn K, Heering H.Helv Chir Acta. 1979 Aug;46(3):309-13.PMID: 226504 German.
Influence of the Lewis blood group system on clinical kidney transplantation.
Fischer E, Lenhard V, Römer W, Dreikorn K, Schärer K, Roelcke D.Proc Eur Dial Transplant Assoc. 1979;16:377-82.PMID: 398510
Prognostic significance of B and T cell antibodies in kidney transplantation.
Lenhard V, Rettwitz W, Dreikorn K, Röhl L.Proc Eur Dial Transplant Assoc. 1980;17:478-82.PMID: 7017693
Skin test reactivity and lymphocyte subsets in cyclosporine versus azathioprine-treated renal transplant recipients.
Pomer S, Daniel V, Dreikorn K, Röhl L.Transplant Proc. 1987 Feb;19(1 Pt 2):1568-9.PMID: 3079026 Clinical Trial.
Preservation and transplantation of human cadaver kidneys. Experiences with the Gamgro perfusion unit.
Dreikorn K, Röhl L.Scand J Urol Nephrol. 1974;8(1):19-26. doi: 10.3109/00365597409132812.PMID: 4595808
Alloplastic replacement of the canine ureter by expanded polytetrafluoroethylene (gore-tex) grafts. Preliminary report.
Dreikorn K, Löbelenz J, Horsch R, Röhl L.Eur Urol. 1978;4(5):379-81. doi: 10.1159/000473998.PMID: 71047
MLR inhibitory activity of pretransplant anti-donor B cell antibodies, and kidney graft survival.
Lenhard V, Diehm H, Rettwitz W, Dreikorn K.Proc Eur Dial Transplant Assoc. 1981;18:433-8.PMID: 6460245
Effect of allogeneic blood transfusions on the growth of two different tumours in the rat.
Rössler W, Dreikorn K, Lenhard V, Zeller WJ, Scholler P.Urol Int. 1985;40(4):217-9. doi: 10.1159/000281083.PMID: 4049579
Bone mineral content after renal transplantation. Placebo-controlled prospective study with 1,25-dihydroxy vitamin D3.
Neubauer E, Neubauer N, Ritz E, Dreikorn K, Krause KH.Klin Wochenschr. 1984 Jan 16;62(2):93-6. doi: 10.1007/BF01769669.PMID: 6368958 Clinical Trial.
[Mechanical kidney preservation. First clinical experiences with a new perfusion unit using a 4 per cent albumin solution as perfusate].
Dreikorn K, Boettger F.Urologe A. 1973 Jan;12(1):28-31.PMID: 4567842 German.
[Current status of renoprotective procedures in the surgery of impaired kidneys].
Dreikorn K, Horsch R.Urologe A. 1984 Jan;23(1):3-8.PMID: 6539013 German
Significance of Lewis and HLA system in kidney transplantation: a multicenter study in Germany.
Lenhard V, Roelcke D, Dreikorn K, Wernet P, Müller G, Bockhorn H, Dorn-Zachertz D, Fassbinder W, Fetta RF, Jansen AM, Wilms H, Halbfass HJ, Gumbel B, Albert FW, Ewald RW, Sprenger-Klasen I, Fischer M, Goldmann SF.Transplant Proc. 1981 Mar;13(1 Pt 2):930-3.PMID: 7022963
Cytomegalovirus (CMV) infections in renal transplant recipients. Preliminary results of prophylaxis by an intramuscular human hyperimmune CMV IgG.
Dreikorn K, Doerr HW, Geursen RG.Scand J Urol Nephrol Suppl. 1985;92:15-21.PMID: 3008312 Clinical Trial
An experimental model for extracorporeal renal surgery: ex situ removal of artificially induced renal staghorn calculi in ambiothermia.
Dreikorn K, Röhl L, Heering H.Eur Urol. 1977;3(5):303-6. doi: 10.1159/000472122.PMID: 334553
Alloplastic replacement of the partially resected canine urethra by expanded polytetrafluoroethylene grafts. Preliminary results.
Dreikorn K, Löbelenz J, Horsch R, Röhl L.Urol Res. 1979 Mar 23;7(1):19-21. doi: 10.1007/BF00262921.PMID: 452179
[Report at the Annual Meeting of the Kidney Transplantation Working Group of the Graduate and Continuing Education Committee of German Urologists. Lübeck 24-26 June 1999].
Frese R, Fornara P, Dreikorn K. Urologe A. 2000 May;39(3):286-9. doi: 10.1007/s001200050357.PMID: 10872256 German
[Successful pregnancy after kidney transplantation and cyclosporin A].
Grischke E, Kaufmann M, Dreikorn K, Linderkamp O, Kubli F.Geburtshilfe Frauenheilkd. 1986 Mar;46(3):176-9. doi: 10.1055/s-2008-1036189.PMID: 3516790 German.
HBV DNA and other hepatitis B virus markers in sera from long-term hemodialysis and kidney transplant patients.
Theilmann L, Gmelin K, Rambausek M, Dreikorn K, Bommer J, Kommerell B, Pfaff E.Hepatogastroenterology. 1988 Aug;35(4):147-50.PMID: 3053386
[Increased success rate of renal transplantation by HLA-DR-typing: a retrospective analysis of the South-German co-operative study group for renal transplantation (author’s transl)].
Müller G, Bockhorn H, Lenhard V, Fischer E, Dreikorn K, Fetta RF, Jansen A, Halbfass HJ, Wilms H, Dorn-Zachertz D, Fassbinder W, Gumbel B, Albert FW, Ewald RW, Goldmann S, Franz HE, Wernet P.Dtsch Med Wochenschr. 1980 Mar 21;105(12):401-5. doi: 10.1055/s-2008-1070675.PMID: 6988187 German.
[Contribution of digital subtraction angiography to the diagnosis of rejection reactions after kidney transplantation].
Prager P, Clorius JH, Dreikorn K. Rofo. 1985 Oct;143(4):426-31. doi: 10.1055/s-2008-1052837.PMID: 2997869 German.
The use of double renal transplants from paediatric cadaver donors.
Dreikorn K, Röhl L, Horsch R.Br J Urol. 1977 Oct;49(5):361-4. doi: 10.1111/j.1464-410x.1977.tb04155.x.PMID: 33808
Results of kidney transplantation in relation to HLA-A, B, DR matching and quality of donor organ.
Lenhard V, Dreikorn K, Röhl L.Proc Eur Dial Transplant Assoc. 1980;17:450-6.PMID: 7017689
[Causes of hypertension following kidney transplantation with special reference to arterial stenoses].
Dreikorn K, Horsch R, Röhl L, Gerhardt P, Prager P.Urologe A. 1985 Jan;24(1):39-45. PMID: 3885544 German.
Seit 01/2022 Ärztlicher Leiter Praxisklinik „Urologie-Süd“
07/2010-12/2021 Chefarzt der Urologischen Klinik München-Harlaching
01/2007-06/2010 Stellvertretender Klinikdirektor und Leitender Oberarzt der Urologischen Klinik und Poliklinik der Ludwig-Maximilians-Universität München
02/2003-12/2006 Oberarzt der Urologischen Klinik der LMU München
12/2001 Facharzt für Urologie
12/1994-12/1995 Praktisches Jahr in St. Gallen, Zürich, San Francisco und München
04/1996-07/1997 Assistenzarzt an der Urologischen Klinik des Kantonspital St. Gallen, Schweiz (Prof. Dr. D. Ackermann)
08/1997-07/1998 Assistenzarzt an der Chirurgischen Klinik des Kantonspital St. Gallen, Schweiz (Prof. Dr. J. Lange)
08/1998-08/1999 Wissenschaftlicher Angestellter an der Urologischen Klinik der Gutenberg-Universität Mainz (Prof. Dr. J. Thüroff)
08/1999-01/2003 Wissenschaftlicher Mitarbeiter der Urologischen Klinik der LMU München (Prof. Dr. Dr. hc. mult. A Hofstetter)
Faul P, Farin G, Reich O, Steude U
The „Band-Electrode“: First Experiences with a novel TURP Procedure to improve Hemostasis.
European Urology; 30(3): 403-408, 1996 (IF 6,512)
Faul P, Farin G, Reich O
Improvement of hemostasis during TUR-P by a modified resection -technique and -electrode (bandloop).
Urologe; 37: 569-576, 1997 (IF 0,391)
Corvin S, Liedl B, Adam C, Zaak D, Reich O, Stürminger P, Hofstetter A
Simultaneous Microsurgical Spermatic Vein Ligation and Sclerotherapy: A combined procedure for the treatment of recurrent or persistent varicocele.
European Urology; 40(3): 350-3, 2001 (IF 6,512)
Reich O, Corvin S, Oberneder R, Sroka R, Muschter R, Hofstetter A
In-vitro comparison of transurethral vaporization of the prostate (TUVP), resection of the prostate (TURP) and vaporization-resection of the prostate (TUVRP)
Urological Research; 30:15-20, 2002 (IF 1,615)
Corvin S, Schneede P, Siakavara E, Frimberger D, Zaak D, Siebels M, Reich O, Hofstetter A
Interstitial laser coagulation combined with minimal transurethral resection of the prostate for the treatment of benign prostatic hyperplasia.
Journal of Endourology; 16(6):387-90, 2002 (IF 1,930)
Reich O, Schneede P, Zaak D, Siebels M, Hofstetter A
Ex-vivo-comparison of the hemostatic properties of transurethral resection of the prostate (TURP) and transurethral vaporization of the prostate (TUVRP)
British Journal of Urology International; 92(3): 319-22, 2003 (IF 2,704)
Reich O, Schneede P, Mseddi A, Zaak D, Siebels M, Hofstetter A
Argon Plasma Coagulation for endourological procedures: ex-vivo evaluations of hemostatic properties.
European Urology; 44(2): 272-6, 2003 (IF 6,512)
Reich O, Schneede P, Corvin S, Zaak D, Sroka R, Hofstetter A
Combination of Interstitial Laser Coagulation (ILC) and Transurethral Resection of the Prostate (TURP): Ex-vivo-evaluations
Urology; 61(6): 1172-76, 2003 (IF 2,242)
Reich O, Hungerhuber E, Hofstetter A, Siebels M, Gusbeth G, Schneede P
Fluorescence guided laser therapy of urethral warts.
Medical Laser Application; 18(2): 117-22, 2003
Zaak D, Sroka R, Höppner M, Khoder W, Reich O, Tritschler S, Muschter R, Knüchel R, Hofstetter A
Photodynamic therapy by means of 5-ALA induced PPIX in human prostate cancer – preliminary results.
Medical Laser Application; 18(1): 91-95, 2003
Zaak D, Sroka R, Stocker S, Bise K, Lein M, Höppner M, Frimberger D, Schneede P, Reich O, Kriegmair M, Knüchel R, Baumgartner R, Hofstetter A
Photodynamic therapy of prostate cancer by means of 5-aminolevulinic acid-induced protoporphyrin IX – in-vivo experiments on the dunning rat tumor model.
Urologia Internationalis; 72(3):196-202, 2004 (IF 0,891)
Reich O, Faul P
The band electrode: Ongoing experience with a novel TURP loop to improve hemostasis in 265 patients.
Urologia Internationalis; 71(1): 40-45, 2004 (IF 0,891)
Siebels M, Theodorakis J, Schmeller N, Corvin S, Mistry-Burchardi N, Hillebrand G, Frimberger D, Reich O, Land W, Hofstetter A
Risks and complications in 160 living kidney donors who underwent nephroureterectomy
Nephrology Dialysis Transplantation; 18(12): 2648-54, 2003 (IF 3,568)
Reich O, Mseddi A, Zaak D, Trottmann M, Hungerhuber E, Schneede P
The use of argon plasma coagulation (APC) in endourology: In-vitro experiments
Urology; 63(2): 387-91, 2004 (IF 2,242)
Reich O, Michel MS, Schneede P, Liedl B, Hofstetter A
Durability of probes for Interstitial Laser Coagulation (ILC): Impact of power setting and probe design
Journal of Endourology; 18(3): 299-302, 2004 (IF 1,930)
Reich O, Bachmann A, Schneede P, Zaak D, Sulser T, Hofstetter A
Experimental comparison of high power (80W) Potassium Titanyl Phosphate (KTP) Laser Vaporization and Transurethral Resection of the Prostate
Journal of Urology; 171(6): 2502-2504, 2004 (IF 3,952)
Bachmann A, Reich O, Wyler S, Ruszat R, Casella R, Gasser T, Sulser T
The 80 W potassium-titanium-phosphate (KTP) laser vaporization of the prostate. Technique and 6 month follow-up after 70 procedures.
Urologe A; 43(10):1262-1270, 2004 (IF 0,391)
Wendt-Nordahl G, Hacker A, Reich O, Djavan B, Alken P, Michel MS
The Vista System: A New Bipolar Resection Device for Endourological Procedures: Comparison with Conventional Resectoscope.
European Urology; 46(5): 586-590, 2004 (IF 6,512)
Sulser T, Reich O, Wyler S, Ruszat R, Casella R, Hofstetter A, Bachmann A
Photoselective KTP laser vaporization of the prostate: first experiences with 65 procedures.
Journal of Endourology; 18(10): 976-981, 2004 (IF 1,930)
Reich O, Bachmann A, Siebels M, Hofstetter A, Stief C, Sulser T
High Power (80W) Potassium-Titanyl-Phosphate (KTP) Laser Vaporization Of The Prostate In 66 High Risk Patients.
Journal of Urology; 173(1): 158-160, 2005 (IF 3,952)
Bachmann A, Sulser T, Jayet C, Wyler S, Ruszat R, Reich O, Gasser TC, Siebels M, Stief CG, Casella R
Retroperitoneoscopy-assisted cryoablation of renal tumors using multiple 1.5mm ultrathin cryoprobes: a preliminary report.
European Urology; 47(4): 474-479, 2005 (IF 6,512)
Bachmann A, Giannini O, Wolff T, Dickenmann M, Ruszat R, Langer I, Gurke L, Gasser TC, Reich O, Stief CG, Steiger J, Sulser T
Retroperitoneoscopic living donor nephrectomy: a comparison with the open approach in respect of early postoperative pain management.
Transplant Proc; 37(2): 609-612, 2005 (IF 1,055)
Bachmann A, Ruszat R, Wyler S, Reich O, Seifert HH, Muller A, Sulser T.
Photoselective vaporization of the prostate: the Basel experience after 108 procedures.
European Urology; 47(6): 798-804, 2005 (IF 6,512)
Wendt-Nordahl G, Hacker A, Fastenmeier K, Knoll T, Reich O, Alken P, Michel MS
New Bipolar Resection Device for Transurethral Resection of the Prostate: First ex-Vivo and in-Vivo Evaluation
Journal of Endourology; 19(10): 1203-1209, 2005 (IF 1,930)
Reich O, Noll M, Gratzke C, Bachmann A, Waidelich R, Seitz M, Schlenker B, Baumgartner R, Hofstetter A, Stief CG
A high-level virtual reality simulator for endourological procedures of the lower urinary tract
Urology; 67(6): 1144-1448, 2006 (IF 2,242)
Schlenker B, Gratzke C, Reich O, Schorsch I, Seitz M, Stief CG
Preliminary results on the off-label use of duloxetine for the treatment of stress incontinence after radical prostatectomy or cystectomy
European Urology; 49(6):1075-1078, 2006 (IF 6,512)
Ruszat R, Wyler S, Seifert HH, Reich O, Forster T, Stief CG, Sulser T, Bachmann A
Photoselective vaporization of the prostate: Experience with prostate adenomas >80 ccm
Urologe A; 45(7): 858-864, 2006 (IF 0,391)
Ruszat R, Wyler S, Seifert H, Reich O, Forster T, Leippold T, Sulser T, Bachmann A
Photoselective vaporization of the prostate: Subgroup analysis of men with refractory urinary retention
European Urology; 50(5): 1040-1049, 2006 (IF 6,512)
Ruszat R, Wyler S, Forster T, Reich O, Stief CG, Gasser TC, Sulser T, Bachmann A
Safety and Effectiveness of Photoselective Vaporization of the Prostate (PVP) in Patients on Ongoing Oral Anticoagulation
European Urology; 51(4): 1031-1038, 2007 (IF 6,512)
Gratzke C, Ückert S, Kedia G, Reich O, Schlenker B, Seitz M, Stief CG
In vitro effects of PDE-5 inhibitors sildenafil, vardenafil and tadalafil on isolated human ureteral smooth muscle: a basic research approach
Urological Research; 35(1): 49-54, 2007 (IF 1,615)
Gratzke C, Schlenker B, Seitz M, Karl A, Hermanek PH, Lack N, Stief CG, Reich O
Complications and early postoperative outcome after open prostatectomy in patients with benign prostatic enlargement: results of a prospective multicenter study
Journal of Urology; 177(4): 1419-1422, 2007 (IF 3,952)
Bader M, Hecht V, Hocaoglu Y, Staehler M, Reich O, Stief C, Sroka R
Technical aspects of intraoperative assessment of treatment progress in laser lithotripsy
Urologe A; 46(9): 1019-1026, 2007 (IF 0,391)
Gratzke C, Ückert S, Reich O, Schlenker B, Tilki D, Seitz M, Stief CG
PDE5 inhibitors: A new option in the treatment of ureteral colic ?
Urologe A; 46(9): 1219-1223, 2007 (IF 0,391)
Seitz M, Sroka R, Gratzke C, Schlenker B, Steinbrecher V, Khoder W, Tilki D, Bachmann A, Stief CG, Reich O
The Diode laser: A novel side-fire approach for laser vaporisation of the human prostate – Immediate efficacy and 1-year follow-up
European Urology; 52(6): 1717-1722, 2007 (IF 6,512)
Seitz M, Ackermann A, Gratzke C, Schlenker B, Ruszat R, Bachmann A, Stief C, Reich O, Sroka R
Diode laser: Ex-vivo studies on vaporization and coagulation characteristics
Urologe A; 46(9): 1242-1247, 2007 (IF 0,391)
Bader MJ, Hecht V, Hocaoglu Y, Tilki D, Staehler M, Wondrazek F, Reich O, Stief CG, Sroka R
In-vitro comparison of laser-induced lithotripsy on artificial stones by means of different laser systems
Medical Laser Application; 22(4): 220-26, 2008
Sroka R, Ackermann A, Tilki D, Reich O, Steinbrecher V, Hofstetter A, Stief CG, Seitz M
In-vitro comparison of the tissue vaporisation capabilities of different lasers.
Medical Laser Application; 22(4): 227-31, 2008
Zaak D, Sroka R, Khoder W, Adam C, Tritschler S, Karl A, Reich O, Knüchel R, Baumgartner R, Tilki D, Popken G, Hofstetter A, Stief C
Photodynamic diagnosis of prostate cancer using 5-aminolevulinic acid – First clinical experiences
Urology; 72(2): 345-348,2008 (IF 2,242)
Ruszat R, Seitz M, Wyler SF, Abe C, Riecken M, Reich O, Gasser TC, Bachmann A
Greenlight Laservaporization of the Prostate: Single-center experience and log-term results after 500 procedures
European Urology; 54(4): 893-901, 2008 (IF 6,512)
Tilki D, Kilic N, Herbst H, Reich O, Seitz M, Lauke H, Stief C, Ergün S
High level of endostatin in epididymal epithelium: Protection against primary malignancies in this organ ?
Histochem Cell Biol; 130(3): 527-535, 2008 (IF 2,320)
Reich O, Gratzke C, Bachmann A, Seitz M, Schlenker B, Hermanek PH, Lack N, Stief CG; Urology Section of the Bavarian Working Group for Quality Assurance
Morbidity, mortality and early outcome of transurethral resection of the prostate: A multicenter evaluation of 10654 patients
Journal of Urology; 180(1): 246-249, 2008 (IF 3,952)
Ruszat R, Wyler SF, Seitz M, Lehmann K, Abe C, Bonkat G, Riecken M, Reich O, Gasser TC, Bachmann A
Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study
British Journal of Urology International; 102(10):1432-1438, 2008 (IF 2,704)
Seitz M, Ruszat R, Bayer T, Tilki D, Bachmann A, Stief C, Sroka R, Reich O
Ex vivo and in vivo investigations of the novel 1,470 nm diode laser for potential treatment of benign prostatic enlargement.
Laser Med Sci; 24(3):419-24, 2009 (IF 1,675)
Holdenrieder S, Burges A, Reich O, Spelsberg FW, Stieber P
DNA integrity in plasma and serum of patients with malignant and benign diseases
Ann NY Acad Sci; 1137:162-170, 2008 (IF 2,303)
Seitz M, Reich O, Gratzke C, Schlenker B, Karl A, Bader M, Khoder W, Fischer F, Stief C, Sroka R
High-power diode laser at 980 nm for the treatment of benign prostatic hyperplasia: ex-vivo investigations on porcine kidneys and human cadaver prostates
Laser Med Sci; 24(2): 172-178, 2009 (IF 1,675)
Seitz M, Bayer T, Ruszat R, Tilki D, Bachmann A, Gratzke C, Schlenker B, Stief C, Sroka R, Reich O
Preliminary evaluation of a novel side-fire diode laser emitting light at 940 nm for the potential treatment of benign prostatic hyperplasia: ex-vivo and in-vivo investigations
British Journal of Urology International; 103(6):770-775, 2009 (IF 2,704)
Gratzke C, Seitz M, Bayrle F, Schlenker B, Bastian PJ, Haseke N, Bader M, Tilki D, Roosen A, Karl A, Reich O, Khoder W, Wyler S, Stief CG, Staehler M, Bachmann A
Quality of life and perioperative outcomes after retroperitoneoscopic radical nephrectomy (RN), open RN and nephron-sparing surgery in patients with renal cell carcinoma
British Journal of Urology International; 104(4):470-5, 2009 (IF 2,704)
Ruszat R, Seitz M, Wyler SF, Müller G, Rieken M, Bonkat G, Gasser TC, Reich O, Bachmann A
Prospective single-centre comparison of 120-W diode-pumped solid-state high-intensity system laser vaporization of the prostate and 200-W high-intensive diode-laser ablation of the prostate for treating benign prostatic hyperplasia.
British Journal of Urology International; 104(6):820-5, 2009 (IF 2,704)
Seitz M, Liedl B, Becker A, Gratzke C, Reich O, Stief C
Upper transverse scrotal approach for muscle- and nerve-sparing urethral stricture repair
World J Urol; 27(5):667-72 (IF 2,699)
Adam C, Salomon G, Walther S, Zaak D, Khoder W, Becker A, Reich O, Blana A, Ganzer R, Denzinger S, Popken G, Sroka R, Knuechel R, Köllermann J, Sauter G, Hartmann A, Bertz S, Graefen M, Huland H, Wieland W, Stief C
Photodynamic Diagnosis Using 5-Aminolevulinic Acid for the Detection of Positive Surgical Margins during Radical Prostatectomy in Patients with Carcinoma of the Prostate: A Multicentre, Prospective, Phase 2 Trial of a Diagnostic Procedure
European Urology; 55(6):1281-8, 2009 (IF 6,512)
Reich O, Schlenker B, Gratzke C, Tilki D, Riecken M, Stief C, Seitz M, Bachmann A
Plasma-Vaporisation of the prostate: Initial clinical results
European Urology; 2009 May 26. [Epub ahead of print] (IF 6,512)
Tilki D, Singer BB, Shariat SF, Behrend A, Fernando M, Irmak S, Buchner A, Hooper AT, Stief CG, Reich O, Ergün S
CEACAM1 – a novel urinary marker for bladder cancer detection
European Urology; 2009 May 28. [Epub ahead of print] (IF 6,512)
Seitz M, Gratzke C, Schlenker B, Buchner A, Karl A, Roosen A, Singer B, Bastian P, Ergün S, Stief C, Reich O, Tilki D
Contrast-Enhanced Transrectal Ultrasound (CE-TRUS) with Cadence-Contrast Pulse Sequence (CPS) Technology for the Detection of Prostate Cancer
Urol Oncol; 2009 June 11. [Epub ahead of print] (IF 2,662)
Gratzke C, Weinhold P, Reich O, Seitz M, Schlenker B, Stief CG, Andersson KE, Hedlund P
Transient Receptor Potential A1 and Cannabinoid Receptor Activity in Human Normal and Hyperplastic Prostate: Relation to Nerves and Interstitial Cells
European Urology; 2009 Aug 28. [Epub ahead of print] (IF 6,512)
Tilki D, Zaak D, Trottmann M, Buchner A, Ekiz Y, Gerwens N, Schlenker B, Karl A, Walther S, Bastian PJ, Gratzke C, Tritschler S, Knüchel-Clarke R, Ergün S, Stief CG, Reich O*, Seitz M*
*Shared senior authorship
Radical cystectomy in the elderly patient: a contemporary comparison of perioperative complications in a single institution series
World J Urol; 2009 Oct 22. [Epub ahead of print] (IF 2,699)
Tilki D, Schlenker B, John M, Buchner A, Stanislaus P, Gratzke C, Karl A, Tan GY, Ergün S, Tewari AK, Stief CG, Seitz M, Reich O
Clinical and pathological predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution series
Urol Oncol; 2009 Oct 16. [Epub ahead of print] (IF: 2,662)
Tilki D, Svatek RS, Karakiewicz PI, Isbarn H, Reich O, Kassouf W, Fradet Y, Novara G, Fritsche H, Bastian PJ, Izawa JI, Stief CG, Ficarra V, Lerner SP, Schoenberg M, Dinney CP, Skinner E, Lotan Y, Sagalowsky AI, Shariat SF
Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patients
Journal of Urology; 183(1): 87-93, 2010 (IF 3,952)
Schlenker B, Tilki D, Gratzke C, Seitz M, Reich O, Schneede P, Stief CG, Hungerhuber E
Intermediate-differentiated invasive (pT1 G2) penile cancer – oncological outcome and follow-up
Urol Oncol; 2009 Nov 26. [Epub ahead of print] (IF 2,662)
Schlenker B, Gratzke C, Seitz M, Bader MJ, Reich O, Schneede P, Hungerhuber E, Stief CG, Tilki D
Fluorescence-guided laser therapy for penile carcinoma and precancerous lesions: long-term follow up.
Urol Oncol; 2009 Nov 26. [Epub ahead of print] (IF 2,662)
Schlenker B, Scher B, Tiling R, Siegert S, Hungerhuber E, Gratzke C, Tilki D, Reich O, Schneede P, Bartenstein P, Stief CG, Seitz M
Detection of Inguinal Lymph Node Involvement in Penile Squamous Cell Carcinoma by 18F-Fluorodeoxyglucose PET/CT: A prospective single-center study
Urol Oncol; 2009 Dec 16. [Epub ahead of print] (IF 2,662)
Schlenker B, Tilki D, Seitz M, Bader MJ, Reich O, Schneede P, Hungerhuber E, Stief CG, Gratzke C
Organ-preserving Nd:YAG laser therapy for penile carcinoma: long-term follow up
British Journal of Urology International; 2010 Jan 19. [Epub ahead of print] (IF: 2,704)
Schlenker B, Seitz M, Bader MJ, Ganzer R, Tilki D, Bayrle F, Reich O, Staehler M, Bachmann A, Stief CG, Gratzke C
Comparison of guideline recommendations with daily practice in patients with renal cell carcinoma
Eur J Med Res; in press 2009 (IF: 1,040)
Schlenker B, Gratzke C, Seitz M, von Walter P, Tilki D, Reich O, Zaak D, Stief CG, Bader MJ
Minimizing complications during retropubic radical prostatectomy – is ureteral stenting necessary?
Eur J Med Res; in press 2009 (IF: 1,040)
Tilki D, Reich O, Svatek RS, Karakiewicz PI, Kassouf W, Novara G, Ficarra V, Chade DC, Fritsche H, Gerwens N, Izawa JI, Lerner SP, Schoenberg M, Stief CG, Skinner E, Lotan Y, Sagalowsky AI, Shariat SF
Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients
Journal of Urology; in press 2009 (IF 3,952)
Tilki D*, Reich O*, Karakiewicz PI, Novara G, Kassouf W, Ergün S, Fradet Y, Ficarra V, Sonpavde G, Stief CG, Skinner E, Svatek RS, Lotan Y, Sagalowsky AI, Shariat SF
*Shared first authorship
Validation of the AJCC TNM substaging of pT2 bladder cancer: deep muscle invasion is associated with significantly worse outcome
European Urology; 2010 Jan 20. [Epub ahead of print] (IF: 6,512)
Tilki D, Svatek RS, Karakiewicz PI, Novara G, Seitz M, Sonpavde G, Gupta A, Kassouf W, Fradet Y, Vincenzo Ficarra, Skinner E, Lotan Y, Sagalowsky AI, Stief CG, Reich O, Shariat SF
pT3 substaging is a prognostic indicator in lymph node negative urothelial carcinoma of the bladder
Journal of Urology; in press 2010. (IF: 3,952)
Tilki D, Svatek RS, Novara G, Seitz M, Godoy G, Karakiewicz PI, Kassouf W, Fradet Y, Fritsche HM, Sonpavde G, Izawa JI, Ficarra V, Lerner SP, Schoenberg M, Stief CG, Dinney CP, Skinner E, Lotan Y, Sagalowsky AI, Reich O*, Shariat SF*
*Shared senior authorship
Stage pT0 at radical cystectomy confers an improvement in survival: An international study of 4430 patients
Journal of Urology; in press 2010. (IF: 3,952)
1994-1996 Arzt im Praktikum, Klinik für Allgemein-, Gefäß- und Thoraxchirurgie, Marienhospital Osnabrück
1996-2001 Assistenzarzt, Klinik für Urologie & Kinderurologie, Medizinische Hochschule Hannover
2001 Anerkennung zum deutschen Facharzt für Urologie
2001-2004 Funktionsoberarzt, Klinik für Urologie & Kinderurologie, Medizinische Hochschule Hannover
2003 Europäisches Facharztexamen (EBU Teil 1)
2004 Promotion Urologie, Medizinische Hochschule Hannover (summa cum laude)
2004-2008 Oberarzt und Sektionsleiter Funktionelle & Rekonstruktive Urologie, Klinik für Urologie, Universität Amsterdam, Niederlande
2005 Europäisches Facharztexamen (EBU Teil 2), seitdem Fellow of the European Board of Urology (FEBU)
2008-2017 Oberarzt und Sektionsleiter Funktionelle & Rekonstruktive Urologie, Klinik für Urologie & Kinderurologie, Medizinische Hochschule Hannover
2010 Habilitation Urologie, Medizinische Hochschule Hannover
2016 PhD-Arbeit, Universität Amsterdam, Niederlande
2017 Oberarzt, Klinik für Urologie, Universität Maastricht, Niederlande
Seit 2018 Außerplanmäßiger Professor für Urologie, Medizinische Hochschule Hannover
Seit 2018 Oberarzt, Sektionsleiter Funktionelle Urologie, Leiter des Studien- und Wissenschaftszentrums, Leiter des interdisziplinären Kontinenz- und Beckenbodenzentrums, Klinik für Urologie, Kinderurologie & Urologische Onkologie, St. Antonius-Hospital Gronau
2001 – 2022 17 nationale oder internationale Preise/Auszeichnungen
2002 – 2022 3 nationale oder internationale Forschungsstipendien
280 Publikationen, Gesamt-Impactfaktor >1.000, h-Index 45, i10-Index 141, >10.000 Zitationen (Stand 30.06.2022)
Wichtige Publikationen zum Thema BPS
Kernkompetenzen
Werdegang
Mitgliedschaften
Wissenschaftliche Publikationen
Kernkompetenzen
Werdegang
1996-2003 Medizinstudium LMU München
2003-2004 Arzt im Praktikum, Anatomische Anstalt, LMU München
2004-2010 Assistenzarzt, Klinikum Großhadern, LMU München
2007-2008 Reserch Fellowship, Klinische Pharmakologie, Institute for Regenerative Medicine, Wake Forest University, NC und Universität Lund, Schweden
2010 Ernennung zum Oberarzt
2010 Habilitation
2014 Ernennung zum außerplanmässigen Professor (APL)
2018 Direktor der Urologischen Klinik, Universität Freiburg
Mitgliedschaften
2000-2007 Medizinstudium LMU München
2007-2014 Weiterbildung zum Facharzt für Urologie, Universitätsspital Basel
2013 Research Fellowship Urologic Oncology Weill Cornell Medical College, New York, USA
2016 Habilitation an der Universität Basel
Seit 2017 Niedergelassener Facharzt für Urologie, alta uro AG, Basel und Belegarzt für Urologie an der Merian Iselin Klinik, Basel
Netsch C, Abt D, Rieken M, Gross AJ.
(Wieder) eine Revolution in der Therapie des benignen Prostatasyndroms? Aquaablation und Prostataembolisation [A (new) revolution in the treatment of benign prostatic hyperplasia? Aqua-ablation and prostate embolization].
Urologe A. 2020 Oct;59(10):1177-1186. German. doi: 10.1007/s00120-020-01312-8. PMID: 32886138.
link
Rieken M, Herrmann TRW, Füllhase C.
Operative Therapie des benignen Prostatasyndroms – resezieren, vaporisieren oder enukleieren? [Surgical treatment of benign prostatic hyperplasia-resection, vaporization or enucleation?].
Urologe A. 2019 Mar;58(3):263-270. German. doi: 10.1007/s00120-019-0891-8. PMID: 30847529.
link
Bschleipfer T, Oelke M, Rieken M.
Diagnostik und diagnostische Strategie beim benignen Prostatasyndrom : Ein Überblick [Diagnostic procedures and diagnostic strategy for lower urinary tract symptoms/benign prostatic hyperplasia : An overview].
Urologe A. 2019 Mar;58(3):238-247. German. doi: 10.1007/s00120-019-0870-0. PMID: 30796463.
link
1978-1985 Studium der Humanmedizin an den Universitäten Essen und Wien
1985 Approbation
1987 Promotion zum Dr. med. (summa cum laude)
1985-1987 Wissenschaftlicher Mitarbeiter, Klinik für Nephrologie und Hypertensiologie, Universität Essen
1987-1989 Wissenschaftlicher Mitarbeiter, Department of Pharmacology, University of California San Diego
1989-1993 Arbeitsgruppenleiter Nephrologisches Labor, Universität Essen
1990 Facharzt für Pharmakologie und Toxikologie
1991-2002 Assistant Adjunct Professor of Pharmacology, University of California San Diego
1993-2002 Leiter Nephrologisches Labor, Universität Essen
1997 Facharzt für Klinische Pharmakologie
1998-1999 Professor und kommissarischer Leiter, Institut für Pharmakologie und Toxikologie, Ruhr-Universität Bochum
2003-2011 Professor und Leiter, Institut für Pharmakologie und Pharmakotherapie, Universität Amsterdam
2004-2011 sowie seit 2016 Mitglied des Abeitskreises Benignes Prostatasyndrom der Deutschen Gesellschaft für Urologie
2011-2016 Globaler Leiter Product & Pipeline Scientific Support, Boehringer Ingelheim
Seit 2012 Professor für Pharmakologie, Johannes Gutenberg Universität Mainz
Seit 2020 Mitglied des Arbeitskreises Urologische Funktionsdiagnostik und Urologie der Frau der Deutschen Gesellschaft für Urologie
>500 begutachtete Publikationen, in der Summe >29.000 mal zitiert, h-Index 87 (Google Scholar)
M. C. Michel, L. Mehlburger, H. U. Bressel, H. Schumacher, R. F. Schäfers, M. Goepel (1998)
Tamsulosin treatment of 19,365 patients with lower urinary tract symptoms: does comorbidity alter tolerability?
J Urol 160: 784-791. DOI 10.1097/00005392-199809010-00043
Link
M. M. Barendrecht, P. Abrams, H. Schumacher, J. J. M. C. H. de la Rosette (2008)
Do α1-adrenoceptor antagonist improve lower urinary tract symptoms by reducing bladder outlet resistance?
Neurourol Urodyn 27: 226-230. DOI 10.1002/nau.20481
Link
M. C. Michel (2010)
The forefront of novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: α-blockers in the treatment of male voiding dysfunction – how do they work and why do they differ in tolerability?
J Pharmacol Sci 112: 151-157. DOI 10.1254/jphs.09r15fm
Link
M. Oelke, A. Bachmann, A. Decazeaud, M. Emberton, S. Gravas, M. C. Michel, J. N’Dow, J. Nordling, J. J. M. C. H. de la Rosette (2013)
EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary symptoms (LUTS), including benign prostatic obstruction.
Eur Urol 64: 118-140. DOI 10.1016/j.eururo.2013.03.004
Link
A. E. Müderrisoglu, K. F. Becher, S. Madersbacher, M. C. Michel (2019)
Cognitive and mood side effects of lower urinary tract medication.
Exp Opin Drug Saf 18: 915-923. DOI 10.1080/14740338.2019.1652269
Link
M. C. Michel, H. Schumacher, L. Mehlburger, J. J. M. C. H. de la Rosette (2020)
Factors associated with nocturia-related quality of life in men with lower urinary tract symptoms and treated with tamsulosin oral controlled absorptio
Herausgeberschaften Wissenschaftlicher Zeitschriften
Preise und Auszeichnungen
2002-2011 Studium der Humanmedizin an der LMU München
2007-2012 Doktorand und wissenschaftlicher Postdoc AG Schubert am Max von Pettenkofer-Institut, LMU
seit 09.2012 Assistenzarzt der Urologie an der Urologischen Klinik und Poliklinik der Universität München, LMU
seit 04.2019 Oberarzt an der Urologischen Klinik und Poliklinik der Universität München, LMU
Magistro G, Chapple CR, Elhilali M, Gilling P, McVary KT, Roehrborn CG, Stief CG, Woo HH, Gratzke C.
Emerging Minimally Invasive Treatment Options for Male Lower Urinary Tract Symptoms.
Eur Urol. 2017 Dec;72(6):986-997
Magistro G, Stief CG, Gratzke C.
New intraprostatic injectables and prostatic urethral lift for male LUTS.
Nat Rev Urol. 2015 Aug;12(8):461-71
Magistro G, Stief CG.
Surgery for benign prostatic obstruction.
Lancet. 2020 Jul 4;396(10243):5-7
Magistro G, Schott M, Keller P, Tamalunas A, Atzler M, Stief CG, Westhofen T.
Enucleation vs. Resection: A Matched-pair Analysis of TURP, HoLEP and Bipolar TUEP in Medium-sized Prostates.
Urology. 2021 Apr 21
Tamalunas A, Westhofen T, Schott M, Keller P, Atzler M, Stief CG, Magistro G.
The clinical value of holmium laser enucleation of the prostate in octogenarians. Low Urin Tract Symptoms.
2021 Apr;13(2):279-285
Westhofen T, Schott M, Keller P, Tamalunas A, Stief CG, Magistro G.
Superiority of Holmium Laser Enucleation of the Prostate over Transurethral Resection of the Prostate in a Matched-Pair Analysis of Bleeding Complications Under Various Antithrombotic Regimens.
J Endourol. 2021 Mar;35(3):328-334
Magistro G, Keller P, Westhofen T, Schott M, Tamalunas A, Weinhold P, Stief CG.
The significance of a high preoperative PSA level for the detection of incidental prostate cancer in LUTS patients with large prostates.
World J Urol. 2021 May;39(5):1481-1487
Westhofen T, Weinhold P, Kolb M, Stief CG, Magistro G.
Evaluation of Holmium Laser Enucleation of the Prostate Learning Curves with and without a Structured Training Programme.
Curr Urol. 2020 Dec;14(4):191-199
Magistro G, Westhofen T, Stief CG, Weinhold P.
A matched-pair analysis of patients with medium-sized prostates (50 cc) treated for male LUTS with HoLEP or TURP. Low Urin Tract Symptoms.
2020 May;12(2):117-122
Herlemann A, Wegner K, Roosen A, Buchner A, Weinhold P, Bachmann A, Stief CG, Gratzke C, Magistro G.
„Finding the needle in a haystack“: oncologic evaluation of patients treated for LUTS with holmium laser enucleation of the prostate (HoLEP) versus transurethral resection of the prostate (TURP).
World J Urol. 2017 Nov;35(11):1777-1782
13.12.1997 Anerkennung zum Facharzt für Urologie
23.3.1999 Habilitation im Fach Urologie
5.6.1999 Fellow of the European Board of Urology (F.E.B.U.)
1.1.01.30.8.02 Oberarzt an der Urologischen Universitätsklinik Bern, Inselspital
1999 Ernennung zum außerordentlichen Universitätsprofessor
1.10.2002 Oberarzt an der Urologischen Abteilung, Donauspital
1.12.2002-3/2014 Stellvertreter des Vorstandes, Urologische Abteilung, Donauspital,
Seit 4/2014 Vorstand, Abteilung für Urologie, Kaiser-Franz-Josef Spital, Wien
Seit 4/2017 Vorstand Urologie, Sigmund Freud Privatuniversität
Ernennung zum außerordentlichen Universitätsprofessor
305 Publikationen gelistet in pubmed als Erst, Co- oder Seniorautor (Gesamtimpactfaktor >900), >500 eingeladene nationale und internationale Vorträge, h-Index 57
Eredics K, Luef T, Madersbacher S
The future of urology: nonagenarians admitted to a urological ward.
World J Urol. 2021 Feb 1. doi: 10.1007/s00345-020-03582-5. Online ahead of print.PMID:33521881
Eredics K, Röthlin F, Wachabauer D, Sevcenco S, Marszalek M, Mock K, Madersbacher S
The long-term outcome of urethrotomy for primary urethral strictures: a population-based analysis.
BJU Int. 2021 Jan 23. doi: 10.1111/bju.15347. Online ahead of print.PMID:33484218
De Nunzio C, Brucker B, Bschleipfer T, Cornu JN, Drake MJ, Fusco F, Gravas S, Oelke M, Peyronnet B, Tutolo M, van Koeveringe G, Madersbacher S
Beyond antimuscarinics: a review of pharmacological and Interventional options for overactive bladder management in men.
Eur Urol. 2021 Apr;79(4):492-504
Madersbacher S, Oelke M, Häcker A, Bschleipfer T
Sophisticated surgical management of distinctive patients with benign prostatic hyperplasia (BPH).
Urologe A. 2020 Oct;59(10):1168-1176. doi: 10.1007/s00120-020-01310-w.PMID:32845346
Madersbacher S, Roehrborn CG, Oelke M
The role of novel minimally invasive treatments for lower urinary tract symptoms associated with benign prostatic hyperplasia.
BJU Int. 2020 Sep;126(3):317-326. doi: 10.1111/bju.15154. Epub 2020 Aug 3.PMID:32599656
Eredics K, Meyer C, Gschliesser T, Lodeta B, Heissler O, Kunit T, Madersbacher S
Can a Simple Geriatric Assessment Predict the Outcome of TURP?
Urol Int. 2020;104(5-6):367-372. doi: 10.1159/000506717. Epub 2020 Apr 1.PMID:32235127
Madersbacher S, Sampson N, Culig Z
Pathophysiology of Benign Prostatic Hyperplasia and Benign Prostatic Enlargement: A Mini-Review.
Gerontology. 2019;65(5):458-464. doi: 10.1159/000496289. Epub 2019 Apr 3.PMID:30943489.
Karavitakis M, Kyriazis I, Omar MI, Gravas S, Cornu JN, Drake MJ, Gacci M, Gratzke C, Herrmann TRW, Madersbacher S, Rieken M, Speakman MJ, Tikkinen KAO, Yuan Y, Mamoulakis C.
Management of urinary retention in patients with benign prostatic obstruction: a systematic review and meta-analysis.
Eur Urol. 2019 May;75(5):788-798. doi: 10.1016/j.eururo.2019.01.046. Epub 2019 Feb 14.PMID:30773327
Eredics K, Bretterbauer KM, Comploj E, Friedl A, Gschliesser T, Lenart S, Seklehner S, Wimpissinger F, Madersbacher S
Bladder cancer in nonagenarians: a multicentre study of 123 patients.
BJU Int. 2018 Dec;122(6):1010-1015. doi: 10.1111/bju.14419. Epub 2018 Jul 26.PMID:29804311
Eredics K, Wachabauer D, Röthlin F, Madersbacher S, Schauer I
Reoperation rates and mortality after transurethral and open Prostatectomy in alLong-term nationwide analysis: have we improved over a decade?
Urology. 2018 Aug;118:152-157. doi: 10.1016/j.urology.2018.04.032. Epub 2018 May 4.PMID:29733869
Studium Friedrich-Alexander Universität Erlangen-Nürnberg (FAU)
Dissertation Institut für Pharmakologie und Toxikologie (FAU)
Facharzt für Urologie: spez. Operative (FMH)
Fellow of the European Board of Urology (FEBU)
Urologische Ausbildung am Kantonsspital St. Gallen (Schweiz), hier bis April 2021 Leitender Arzt und Co-Leiter «Experimentelle Urologie»
Habilitation an der Universität Zürich zum Thema «Wirksamkeit und Sicherheit chirurgischer Therapieverfahren beim benignen Prostatasyndrom»
Lehrbeauftragter der Universität Zürich
Seit Mai 2021 Co-Chefarzt am Spitalzentrum Biel/Bienne
A (new) revolution in the treatment of benign prostatic hyperplasia? Aqua-ablation and prostate embolization link
Andere zum Thema BPS
Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial
link
Prostatic Artery Embolisation Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: 2-yr Outcomes of a Randomised, Open-label, Single-centre Trial
link
Informative value of histological assessment of tissue acquired during aquablation of the prostate
link
Information on surgical treatment of benign prostatic hyperplasia on YouTube is highly biased and misleading
link
Reasons to consider prostatic artery embolization
link
Radiation Exposure During Prostatic Artery Embolisation: A Systematic Review and Calculation of Associated Risks
link
Outcome prediction of prostatic artery embolization: post hoc analysis of a randomized, open-label, non-inferiority trial
link
Prostatic Artery Embolization versus Standard Surgical Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis
link
